https://newdrugapprovals.org/2026/04/03/anvumetostat/https://newdrugapprovals.org/wp-content/uploads/2026/04/image-17.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/04/image-16.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/04/image-15.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/04/image-14.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/04/image-13.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/04/image-12.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/04/image-11.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/04/image-10.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/04/image-9.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/04/image-8.pngimage2026-04-03T02:48:49+00:00monthlyhttps://newdrugapprovals.org/2026/04/02/andamertinib/https://newdrugapprovals.org/wp-content/uploads/2026/04/image-3.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/04/image-2.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/04/image-1.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/04/image.pngimage2026-04-02T02:27:42+00:00monthlyhttps://newdrugapprovals.org/2026/03/31/amsulostat/https://newdrugapprovals.org/wp-content/uploads/2026/03/image-186.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-185.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-184.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-183.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-182.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-181.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-180.pngimage2026-03-31T02:35:46+00:00monthlyhttps://newdrugapprovals.org/2026/03/30/amezalpat/https://newdrugapprovals.org/wp-content/uploads/2026/03/image-179.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-178.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-177.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-176.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-175.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-2.gifimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-174.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-173.pngimage2026-03-30T02:37:24+00:00monthlyhttps://newdrugapprovals.org/2022/10/31/relacorilant/https://newdrugapprovals.org/wp-content/uploads/2022/10/image.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2022/10/str1-1.pngSTR1https://newdrugapprovals.org/wp-content/uploads/2022/11/wdt-1.jpgwdt-12026-03-29T02:24:36+00:00monthlyhttps://newdrugapprovals.org/2026/03/28/alnodesertib/https://newdrugapprovals.org/wp-content/uploads/2026/03/image-172.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-171.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-170.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-169.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-168.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image.jpegimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-1.jpegimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-167.pngimage2026-03-28T02:37:44+00:00monthlyhttps://newdrugapprovals.org/2026/03/27/alixorexton/https://newdrugapprovals.org/wp-content/uploads/2026/03/image-166.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-165.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-164.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-163.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-162.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-161.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-160.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-159.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-158.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-157.pngimage2026-03-27T02:57:55+00:00monthlyhttps://newdrugapprovals.org/2026/03/26/zeprumetostat/https://newdrugapprovals.org/wp-content/uploads/2026/03/image-144.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-143.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-142.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-141.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-140.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-139.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-138.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-137.pngimage2026-03-26T02:33:21+00:00monthlyhttps://newdrugapprovals.org/2026/03/25/zelebrudomide/https://newdrugapprovals.org/wp-content/uploads/2026/03/image-136.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-135.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-134.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-133.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-132.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-131.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-130.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-129.pngimage2026-03-25T02:35:00+00:00monthlyhttps://newdrugapprovals.org/2026/03/24/zanvipixant/https://newdrugapprovals.org/wp-content/uploads/2026/03/image-128.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-127.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-126.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-125.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-124.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-123.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-122.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-121.pngimage2026-03-24T02:42:40+00:00monthlyhttps://newdrugapprovals.org/2026/03/23/vormatrigine/https://newdrugapprovals.org/wp-content/uploads/2026/03/image-120.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-119.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-118.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-117.pngimage2026-03-23T02:38:22+00:00monthlyhttps://newdrugapprovals.org/2026/03/22/veonetinib/https://newdrugapprovals.org/wp-content/uploads/2026/03/image-116.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-115.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-114.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-113.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-112.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-111.pngimage2026-03-22T02:50:00+00:00monthlyhttps://newdrugapprovals.org/2026/03/20/ulacamten/https://newdrugapprovals.org/wp-content/uploads/2026/03/image-110.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-109.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-108.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-107.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-106.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-105.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-104.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-103.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-102.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-101.pngimage2026-03-20T02:43:05+00:00monthlyhttps://newdrugapprovals.org/2017/07/21/gsk-2330672/https://newdrugapprovals.org/wp-content/uploads/2022/07/wdt.jpgwdt2026-03-20T02:19:45+00:00monthlyhttps://newdrugapprovals.org/2026/03/19/tigemocoxib/https://newdrugapprovals.org/wp-content/uploads/2026/03/image-96.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-95.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-94.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-93.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-92.pngimage2026-03-19T02:38:08+00:00monthlyhttps://newdrugapprovals.org/2026/03/18/teprosulvose/https://newdrugapprovals.org/wp-content/uploads/2026/03/image-91.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-90.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-89.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-88.pngimage2026-03-18T02:43:15+00:00monthlyhttps://newdrugapprovals.org/2026/03/17/suricapavir/https://newdrugapprovals.org/wp-content/uploads/2026/03/image-87.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-86.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-85.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-84.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-83.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-82.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-81.pngimage2026-03-17T02:42:18+00:00monthlyhttps://newdrugapprovals.org/2026/03/16/soxataltinib/https://newdrugapprovals.org/wp-content/uploads/2026/03/image-80.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-79.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-78.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-77.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-76.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-75.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-74.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-73.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-72.pngimage2026-03-16T02:43:57+00:00monthlyhttps://newdrugapprovals.org/2026/03/15/selonabant/https://newdrugapprovals.org/wp-content/uploads/2026/03/image-71.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-70.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-69.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-68.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-67.pngimage2026-03-15T02:58:49+00:00monthlyhttps://newdrugapprovals.org/2026/03/13/rosolutamide/https://newdrugapprovals.org/wp-content/uploads/2026/03/image-66.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-65.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-64.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-63.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-62.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-61.pngimage2026-03-13T02:37:55+00:00monthlyhttps://newdrugapprovals.org/2026/03/12/rivasterat/https://newdrugapprovals.org/wp-content/uploads/2026/03/image-60.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-59.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-58.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-57.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-56.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-55.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-54.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-53.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-52.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-51.pngimage2026-03-12T02:47:00+00:00monthlyhttps://newdrugapprovals.org/2026/03/10/repinatrabit/https://newdrugapprovals.org/wp-content/uploads/2026/03/image-47.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-46.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-45.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-44.pngimage2026-03-10T02:40:14+00:00monthlyhttps://newdrugapprovals.org/2026/03/09/remlifanserin/https://newdrugapprovals.org/wp-content/uploads/2026/03/image-43.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-42.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-41.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-40.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-39.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-38.pngimage2026-03-09T03:01:55+00:00monthlyhttps://newdrugapprovals.org/2026/03/08/relicpixant/https://newdrugapprovals.org/wp-content/uploads/2026/03/image-37.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-36.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-35.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-34.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-33.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-32.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-31.pngimage2026-03-08T02:47:25+00:00monthlyhttps://newdrugapprovals.org/2026/03/07/ranosidenib/https://newdrugapprovals.org/wp-content/uploads/2026/03/image-30.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-29.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-28.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-27.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-26.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-25.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-24.pngimage2026-03-07T02:37:42+00:00monthlyhttps://newdrugapprovals.org/2026/03/06/progerinin/https://newdrugapprovals.org/wp-content/uploads/2026/03/image-23.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-22.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-21.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-20.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-19.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-18.pngimage2026-03-06T02:56:05+00:00monthlyhttps://newdrugapprovals.org/2026/03/05/lead-212pb-bamzireotide-navoxetan/https://newdrugapprovals.org/wp-content/uploads/2026/03/image-17.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-16.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-15.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-14.pngimage2026-03-05T02:25:15+00:00monthlyhttps://newdrugapprovals.org/2026/03/04/pixavir-marboxil/https://newdrugapprovals.org/wp-content/uploads/2026/03/image-13.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-12.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-11.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-10.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-9.pngimage2026-03-04T02:29:01+00:00monthlyhttps://newdrugapprovals.org/2026/03/02/navepegritide/https://newdrugapprovals.org/wp-content/uploads/2026/03/image-8.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-7.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image.gifimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-1.gifimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-6.pngimage2026-03-02T02:56:07+00:00monthlyhttps://newdrugapprovals.org/2026/03/01/pebezertinib/https://newdrugapprovals.org/wp-content/uploads/2026/03/image-5.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-4.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-3.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-2.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image-1.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/03/image.pngimage2026-03-01T03:21:48+00:00monthlyhttps://newdrugapprovals.org/2026/02/28/oveporexton/https://newdrugapprovals.org/wp-content/uploads/2026/02/image-165.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-164.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-163.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-162.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-161.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-160.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-159.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-158.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-157.pngimage2026-02-28T02:44:41+00:00monthlyhttps://newdrugapprovals.org/2026/02/27/orenasitecan/https://newdrugapprovals.org/wp-content/uploads/2026/02/image-156.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-155.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-154.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-153.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-152.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-151.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-150.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-149.pngimage2026-02-27T03:00:17+00:00monthlyhttps://newdrugapprovals.org/2026/02/26/milsaperidone/https://newdrugapprovals.org/wp-content/uploads/2026/02/image-148.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-147.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-146.pngimage2026-02-26T02:23:27+00:00monthlyhttps://newdrugapprovals.org/2026/02/25/olomorasib/https://newdrugapprovals.org/wp-content/uploads/2026/02/image-145.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-144.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-143.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-142.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-141.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-140.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-139.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-138.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-137.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-136.pngimage2026-02-25T03:03:41+00:00monthlyhttps://newdrugapprovals.org/2026/02/24/ocadusertib/https://newdrugapprovals.org/wp-content/uploads/2026/02/image-134.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-133.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-132.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-131.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-130.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-129.pngimage2026-02-24T04:03:36+00:00monthlyhttps://newdrugapprovals.org/2026/02/23/nivegacetor/https://newdrugapprovals.org/wp-content/uploads/2026/02/image-128.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-127.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-126.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-125.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-124.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-123.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-122.pngimage2026-02-23T02:40:29+00:00monthlyhttps://newdrugapprovals.org/2026/02/21/nispomeben/https://newdrugapprovals.org/wp-content/uploads/2026/02/image-121.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-120.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-119.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-118.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-117.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-116.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-115.pngimage2026-02-21T03:14:54+00:00monthlyhttps://newdrugapprovals.org/2026/02/20/nedemelteon/https://newdrugapprovals.org/wp-content/uploads/2026/02/image-114.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-113.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-112.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-111.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-110.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-109.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-108.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-107.pngimage2026-02-20T02:36:58+00:00monthlyhttps://newdrugapprovals.org/2026/02/19/naxtarubicin-annamycin/https://newdrugapprovals.org/wp-content/uploads/2026/02/image-106.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-105.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-104.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-103.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-102.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-101.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-100.pngimage2026-02-19T02:53:12+00:00monthlyhttps://newdrugapprovals.org/2026/02/18/navepdekinra/https://newdrugapprovals.org/wp-content/uploads/2026/02/image-99.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-98.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-97.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-96.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-95.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-94.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-93.pngimage2026-02-18T03:01:21+00:00monthlyhttps://newdrugapprovals.org/2026/02/17/napazimone/https://newdrugapprovals.org/wp-content/uploads/2026/02/image-92.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-91.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-90.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-89.pngimage2026-02-17T02:30:05+00:00monthlyhttps://newdrugapprovals.org/2022/04/17/difamilast/https://newdrugapprovals.org/wp-content/uploads/2022/04/str1.pngSTR1https://newdrugapprovals.org/wp-content/uploads/2022/04/str1-5.jpgSTR1https://newdrugapprovals.org/wp-content/uploads/2022/04/str1-4.jpgSTR12026-02-16T02:41:49+00:00monthlyhttps://newdrugapprovals.org/2026/02/15/nacresertib/https://newdrugapprovals.org/wp-content/uploads/2026/02/image-88.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-87.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-86.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-85.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-84.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-83.pngimage2026-02-15T03:10:47+00:00monthlyhttps://newdrugapprovals.org/2026/02/14/mosperafenib/https://newdrugapprovals.org/wp-content/uploads/2026/02/image-82.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-81.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-80.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-79.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-78.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-77.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-76.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-75.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-74.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-73.pngimage2026-02-14T02:49:34+00:00monthlyhttps://newdrugapprovals.org/2026/02/13/mocaciclib/https://newdrugapprovals.org/wp-content/uploads/2026/02/image-69.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-68.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-67.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-66.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-65.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-64.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-63.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-62.pngimage2026-02-13T02:44:42+00:00monthlyhttps://newdrugapprovals.org/2026/02/12/mobinitinib/https://newdrugapprovals.org/wp-content/uploads/2026/02/image-61.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-60.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-59.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-58.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-57.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-56.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-55.pngimage2026-02-12T02:33:03+00:00monthlyhttps://newdrugapprovals.org/2026/02/10/mevrometostat/https://newdrugapprovals.org/wp-content/uploads/2026/02/image-54.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-53.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-52.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-51.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/s2.jpgS2https://newdrugapprovals.org/wp-content/uploads/2026/02/image-50.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-49.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-48.pngimage2026-02-11T02:26:48+00:00monthlyhttps://newdrugapprovals.org/2026/02/09/maritupirdine/https://newdrugapprovals.org/wp-content/uploads/2026/02/image-47.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-46.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-45.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-44.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-43.pngimage2026-02-09T02:35:25+00:00monthlyhttps://newdrugapprovals.org/2026/02/08/luvometinib/https://newdrugapprovals.org/wp-content/uploads/2026/02/image-1.jpegimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-41.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-42.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-40.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-39.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-38.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-37.pngimage2026-02-08T02:31:42+00:00monthlyhttps://newdrugapprovals.org/2026/02/07/lutetium-177lu-tezuvotide-tetraxetan/https://newdrugapprovals.org/wp-content/uploads/2026/02/image-36.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-35.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-34.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-33.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-32.pngimage2026-02-07T02:38:24+00:00monthlyhttps://newdrugapprovals.org/2026/02/06/lecufexor/https://newdrugapprovals.org/wp-content/uploads/2026/02/image-31.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-30.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-29.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-28.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-27.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-26.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-25.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-24.pngimage2026-02-06T02:39:43+00:00monthlyhttps://newdrugapprovals.org/2026/02/05/laselipag/https://newdrugapprovals.org/wp-content/uploads/2026/02/image-23.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-22.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-21.pngimage2026-02-05T02:30:12+00:00monthlyhttps://newdrugapprovals.org/2026/02/04/laroprovstat/https://newdrugapprovals.org/wp-content/uploads/2026/02/image-20.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-19.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-18.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-17.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-16.pngimage2026-02-04T02:33:28+00:00monthlyhttps://newdrugapprovals.org/2026/02/02/istisociclib-2/2026-02-02T02:37:02+00:00monthlyhttps://newdrugapprovals.org/2026/02/02/istisociclib/https://newdrugapprovals.org/wp-content/uploads/2026/02/image-15.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-14.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-13.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-12.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-11.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-10.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-9.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-8.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-7.pngimage2026-02-02T02:35:43+00:00monthlyhttps://newdrugapprovals.org/2026/02/01/isomiosamine/https://newdrugapprovals.org/wp-content/uploads/2026/02/image-6.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image.jpegimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-5.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-4.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-3.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-2.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image-1.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/02/image.pngimage2026-02-01T03:07:41+00:00monthlyhttps://newdrugapprovals.org/2026/01/31/ismidenon/https://newdrugapprovals.org/wp-content/uploads/2026/01/image-23.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/01/image-22.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/01/image-21.pngimage2026-01-31T02:53:46+00:00monthlyhttps://newdrugapprovals.org/2026/01/30/copper-histidinate/https://newdrugapprovals.org/wp-content/uploads/2026/01/image-20.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/01/image-19.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/01/image-18.pngimage2026-01-30T02:31:11+00:00monthlyhttps://newdrugapprovals.org/2026/01/29/idrebormilast/https://newdrugapprovals.org/wp-content/uploads/2026/01/image-17.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/01/image-16.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/01/image-15.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/01/image-14.pngimage2026-01-29T02:40:18+00:00monthlyhttps://newdrugapprovals.org/2026/01/28/gridegalutamide/https://newdrugapprovals.org/wp-content/uploads/2026/01/image-13.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/01/image-12.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/01/image-11.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/01/image-10.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/01/image-9.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/01/image-8.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/01/image-7.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/01/image-6.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/01/image-5.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/01/image-4.pngimage2026-01-28T03:02:01+00:00monthlyhttps://newdrugapprovals.org/2025/11/30/segatroxaban/2026-01-27T16:21:22+00:00monthlyhttps://newdrugapprovals.org/2026/01/27/glasmacinal/2026-01-27T16:17:02+00:00monthlyhttps://newdrugapprovals.org/2026/01/26/frespaciguat/2026-01-26T02:34:39+00:00monthlyhttps://newdrugapprovals.org/2026/01/25/fosrolapitant/2026-01-25T02:36:02+00:00monthlyhttps://newdrugapprovals.org/2026/01/24/filricianine/2026-01-24T02:31:12+00:00monthlyhttps://newdrugapprovals.org/2026/01/23/fanregratinib/2026-01-23T02:32:34+00:00monthlyhttps://newdrugapprovals.org/2026/01/22/evetifator/2026-01-22T02:35:20+00:00monthlyhttps://newdrugapprovals.org/2026/01/21/evategrel/2026-01-21T02:36:25+00:00monthlyhttps://newdrugapprovals.org/2026/01/20/enrupatinib/2026-01-20T02:32:34+00:00monthlyhttps://newdrugapprovals.org/2026/01/19/emestedastat/2026-01-19T02:35:01+00:00monthlyhttps://newdrugapprovals.org/2026/01/18/direclidine/2026-01-18T02:42:03+00:00monthlyhttps://newdrugapprovals.org/2026/01/17/dezecapavir/https://newdrugapprovals.org/wp-content/uploads/2026/01/str1-1.jpgSTR1https://newdrugapprovals.org/wp-content/uploads/2026/01/str1.jpgSTR12026-01-17T04:08:56+00:00monthlyhttps://newdrugapprovals.org/2026/01/16/deulorlatinib/https://newdrugapprovals.org/wp-content/uploads/2026/01/image-3.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/01/image-2.pngimage2026-01-16T02:54:08+00:00monthlyhttps://newdrugapprovals.org/2026/01/15/cenacitinib/2026-01-15T02:47:43+00:00monthlyhttps://newdrugapprovals.org/2026/01/14/casdatifan/https://newdrugapprovals.org/wp-content/uploads/2026/01/image-1.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2026/01/image.pngimage2026-01-15T02:31:02+00:00monthlyhttps://newdrugapprovals.org/2026/01/13/cambritaxestat/2026-01-13T02:32:30+00:00monthlyhttps://newdrugapprovals.org/2026/01/12/brexanolone-caprilcerbate/2026-01-12T02:55:47+00:00monthlyhttps://newdrugapprovals.org/2026/01/11/branosotine/2026-01-11T02:33:50+00:00monthlyhttps://newdrugapprovals.org/2026/01/09/bosmolisib/2026-01-09T02:52:59+00:00monthlyhttps://newdrugapprovals.org/2026/01/08/beroterkib/2026-01-08T02:41:26+00:00monthlyhttps://newdrugapprovals.org/2026/01/07/balinatunfib/2026-01-07T02:58:51+00:00monthlyhttps://newdrugapprovals.org/2017/02/27/tradipitant-%d1%82%d1%80%d0%b0%d0%b4%d0%b8%d0%bf%d0%b8%d1%82%d0%b0%d0%bd%d1%82-%d8%aa%d8%b1%d8%a7%d8%af%d9%8a%d8%a8%d9%8a%d8%aa%d8%a7%d9%86%d8%aa-%e6%9b%b2%e5%9c%b0%e5%8c%b9%e5%9d%a6/2026-01-06T02:46:13+00:00monthlyhttps://newdrugapprovals.org/2026/01/05/atirmociclib/2026-01-05T03:01:48+00:00monthlyhttps://newdrugapprovals.org/2026/01/04/asaretoclax/2026-01-04T02:34:14+00:00monthlyhttps://newdrugapprovals.org/2026/01/03/doxecitine/2026-01-03T02:34:22+00:00monthlyhttps://newdrugapprovals.org/2026/01/02/amogammadex/2026-01-02T02:52:04+00:00monthlyhttps://newdrugapprovals.org/2025/12/31/alizulatide-vixocianine/2025-12-31T02:40:34+00:00monthlyhttps://newdrugapprovals.org/2025/12/30/aleniglipron/2025-12-30T02:42:59+00:00monthlyhttps://newdrugapprovals.org/2025/12/29/limnetrelvir/2025-12-29T02:44:52+00:00monthlyhttps://newdrugapprovals.org/2025/12/28/aficamten/2025-12-28T02:46:04+00:00monthlyhttps://newdrugapprovals.org/2025/05/28/etripamil/2025-12-27T02:16:45+00:00monthlyhttps://newdrugapprovals.org/2025/12/26/zoliflodacin/2025-12-26T03:13:01+00:00monthlyhttps://newdrugapprovals.org/2025/12/25/iscartrelvir/2025-12-25T02:38:06+00:00monthlyhttps://newdrugapprovals.org/2025/12/24/zoracopan/2025-12-24T03:07:13+00:00monthlyhttps://newdrugapprovals.org/2025/12/23/zopocianine/2025-12-23T02:32:17+00:00monthlyhttps://newdrugapprovals.org/2025/12/22/zomiradomide/2025-12-22T02:37:38+00:00monthlyhttps://newdrugapprovals.org/2025/12/21/zerencotrep/2025-12-21T02:44:08+00:00monthlyhttps://newdrugapprovals.org/2025/12/20/zemprocitinib/2025-12-20T02:54:29+00:00monthlyhttps://newdrugapprovals.org/2025/12/19/zemirciclib/2025-12-19T02:10:48+00:00monthlyhttps://newdrugapprovals.org/2025/12/18/zelenirstat/2025-12-18T03:03:41+00:00monthlyhttps://newdrugapprovals.org/2025/12/17/zavolosotine/2025-12-17T02:29:35+00:00monthlyhttps://newdrugapprovals.org/2025/12/16/zamzetoclax/2025-12-16T02:50:09+00:00monthlyhttps://newdrugapprovals.org/2025/12/15/vilzemetkib/2025-12-15T02:49:09+00:00monthlyhttps://newdrugapprovals.org/2025/12/13/vicadrostat/2025-12-13T06:31:04+00:00monthlyhttps://newdrugapprovals.org/2025/12/13/varegacestat/2025-12-13T03:08:17+00:00monthlyhttps://newdrugapprovals.org/2025/12/12/tigozertinib/2025-12-12T02:50:58+00:00monthlyhttps://newdrugapprovals.org/2025/12/11/tambiciclib/2025-12-11T09:43:52+00:00monthlyhttps://newdrugapprovals.org/2025/12/11/talorasib/2025-12-11T02:25:44+00:00monthlyhttps://newdrugapprovals.org/2025/12/10/talogreptide-mesaroxetan/2025-12-10T02:47:59+00:00monthlyhttps://newdrugapprovals.org/2025/12/09/suvadronabinol/2025-12-09T02:42:39+00:00monthlyhttps://newdrugapprovals.org/2025/12/08/surzetoclax/2025-12-08T02:45:28+00:00monthlyhttps://newdrugapprovals.org/2025/12/07/surlorian/2025-12-07T02:33:53+00:00monthlyhttps://newdrugapprovals.org/2025/12/06/sumecigrel-vicagrel/2025-12-06T03:05:53+00:00monthlyhttps://newdrugapprovals.org/2025/12/05/soquelitinib/2025-12-05T08:51:57+00:00monthlyhttps://newdrugapprovals.org/help-me/https://newdrugapprovals.org/wp-content/uploads/2015/07/09b37-misc2b027.jpg09b37-misc2b0272025-12-05T02:10:56+00:00weekly0.6https://newdrugapprovals.org/2025/12/04/sitokiren/2025-12-04T08:26:56+00:00monthlyhttps://newdrugapprovals.org/2025/12/03/setidegrasib/2025-12-03T10:09:57+00:00monthlyhttps://newdrugapprovals.org/2025/12/02/sendegobresib/2025-12-02T02:59:49+00:00monthlyhttps://newdrugapprovals.org/2025/12/01/segigratinib-ratangratinib/2025-12-02T02:17:26+00:00monthlyhttps://newdrugapprovals.org/2025/11/29/rupitasertib/2025-11-29T03:11:29+00:00monthlyhttps://newdrugapprovals.org/2025/11/28/rogocekib/2025-11-28T03:06:56+00:00monthlyhttps://newdrugapprovals.org/2025/11/27/riselcaftor/2025-11-27T08:31:22+00:00monthlyhttps://newdrugapprovals.org/2025/11/26/pudafensine/2025-11-26T02:40:23+00:00monthlyhttps://newdrugapprovals.org/2025/11/25/privosegtor/2025-11-25T02:41:06+00:00monthlyhttps://newdrugapprovals.org/2025/11/24/pregabalin-naproxencarbil/2025-11-24T10:44:31+00:00monthlyhttps://newdrugapprovals.org/2025/11/24/sevabertinib/2025-11-24T02:48:16+00:00monthlyhttps://newdrugapprovals.org/2025/11/23/plozasiran/2025-11-23T02:44:22+00:00monthlyhttps://newdrugapprovals.org/2025/11/21/ziftomenib/https://newdrugapprovals.org/wp-content/uploads/2025/11/k1.jpgk1https://newdrugapprovals.org/wp-content/uploads/2025/11/image-1.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2025/11/image.pngimage2025-11-22T04:59:35+00:00monthlyhttps://newdrugapprovals.org/2025/11/20/potrasertib/2025-11-20T02:47:08+00:00monthlyhttps://newdrugapprovals.org/2025/11/19/plosaracetam/2025-11-19T08:47:26+00:00monthlyhttps://newdrugapprovals.org/2025/11/18/pilavapadin/2025-11-18T10:11:27+00:00monthlyhttps://newdrugapprovals.org/2025/11/18/paluratide/2025-11-18T02:53:10+00:00monthlyhttps://newdrugapprovals.org/2025/11/16/padoprazan/2025-11-16T02:45:55+00:00monthlyhttps://newdrugapprovals.org/2025/11/15/ofirnoflast/2025-11-15T03:14:03+00:00monthlyhttps://newdrugapprovals.org/2025/11/14/odentegravir/2025-11-14T02:33:35+00:00monthlyhttps://newdrugapprovals.org/2025/11/13/nuvisertib/2025-11-13T02:58:09+00:00monthlyhttps://newdrugapprovals.org/2025/11/12/nurandociguat/2025-11-12T08:50:03+00:00monthlyhttps://newdrugapprovals.org/2025/11/11/nibrozetone/2025-11-11T02:36:39+00:00monthlyhttps://newdrugapprovals.org/2025/11/10/neladalkib/2025-11-10T02:28:44+00:00monthlyhttps://newdrugapprovals.org/2025/11/09/nefextinib/2025-11-09T08:27:12+00:00monthlyhttps://newdrugapprovals.org/2025/11/08/muvadenant/2025-11-08T02:50:54+00:00monthlyhttps://newdrugapprovals.org/2025/11/07/matsupexole/2025-11-07T02:47:47+00:00monthlyhttps://newdrugapprovals.org/2025/11/06/mangaciclanol/2025-11-06T02:48:32+00:00monthlyhttps://newdrugapprovals.org/2025/11/05/elinzanetant/2025-11-05T09:46:48+00:00monthlyhttps://newdrugapprovals.org/2025/11/05/lunresertib/2025-11-05T02:52:54+00:00monthlyhttps://newdrugapprovals.org/2025/11/04/lunbotinib/2025-11-04T11:27:18+00:00monthlyhttps://newdrugapprovals.org/2025/11/03/lomedeucitinib/2025-11-03T09:36:07+00:00monthlyhttps://newdrugapprovals.org/2025/11/03/lirodegimod/2025-11-03T03:02:31+00:00monthlyhttps://newdrugapprovals.org/2025/11/01/linustedastat/2025-11-01T06:01:32+00:00monthlyhttps://newdrugapprovals.org/2025/10/31/iodofalan-131i/2025-10-31T02:27:44+00:00monthlyhttps://newdrugapprovals.org/2025/10/30/inlexisertib/2025-10-30T02:33:26+00:00monthlyhttps://newdrugapprovals.org/2025/10/29/imocitrelvir/2025-10-29T02:36:00+00:00monthlyhttps://newdrugapprovals.org/2025/10/28/ilantimod/https://newdrugapprovals.org/wp-content/uploads/2025/10/c1.jpgC12025-10-28T10:51:24+00:00monthlyhttps://newdrugapprovals.org/2025/10/28/icovamenib/2025-10-28T02:44:38+00:00monthlyhttps://newdrugapprovals.org/2025/10/27/ibrilatazar/2025-10-27T02:43:07+00:00monthlyhttps://newdrugapprovals.org/2025/10/26/glovadalen/2025-10-26T02:31:04+00:00monthlyhttps://newdrugapprovals.org/2025/10/25/girocitinib/2025-10-25T02:45:02+00:00monthlyhttps://newdrugapprovals.org/2025/10/24/gildeuretinol/2025-10-24T02:27:19+00:00monthlyhttps://newdrugapprovals.org/2025/10/23/frevecitinib/https://newdrugapprovals.org/wp-content/uploads/2025/10/image.pngimage2025-10-23T03:07:57+00:00monthlyhttps://newdrugapprovals.org/2025/06/25/nerandomilast/2025-10-23T02:22:57+00:00monthlyhttps://newdrugapprovals.org/2025/10/22/remibrutinib/2025-10-22T08:53:08+00:00monthlyhttps://newdrugapprovals.org/2025/07/07/paltusotine/https://newdrugapprovals.org/wp-content/uploads/2025/07/wdt.jpgWDT2025-10-22T06:20:50+00:00monthlyhttps://newdrugapprovals.org/2025/10/15/fovinaciclib/2025-10-15T02:33:12+00:00monthlyhttps://newdrugapprovals.org/2025/10/14/foselutoclax/2025-10-14T02:31:20+00:00monthlyhttps://newdrugapprovals.org/2025/10/13/fosdesdenosine-sipalabenamide/2025-10-13T02:35:01+00:00monthlyhttps://newdrugapprovals.org/2025/10/12/flezurafenib/2025-10-12T02:42:48+00:00monthlyhttps://newdrugapprovals.org/2025/10/11/ezobresib/2025-10-11T02:36:07+00:00monthlyhttps://newdrugapprovals.org/2025/10/10/epsametostat/2025-10-10T02:31:10+00:00monthlyhttps://newdrugapprovals.org/2025/10/09/enzomenib/2025-10-09T02:41:38+00:00monthlyhttps://newdrugapprovals.org/2025/10/07/envudeucitinib/2025-10-07T10:10:17+00:00monthlyhttps://newdrugapprovals.org/2025/10/05/darbinurad/2025-10-05T08:31:39+00:00monthlyhttps://newdrugapprovals.org/2025/10/01/pharmmaex-mumbai-india-3-4-october-2025/https://newdrugapprovals.org/wp-content/uploads/2025/10/p1.jpgP12025-10-01T03:13:28+00:00monthlyhttps://newdrugapprovals.org/2025/10/01/imlunestrant/2025-10-01T02:39:28+00:00monthlyhttps://newdrugapprovals.org/2025/09/30/dapolsertib/2025-09-30T02:52:05+00:00monthlyhttps://newdrugapprovals.org/2025/09/29/crelosidenib/2025-09-29T08:08:17+00:00monthlyhttps://newdrugapprovals.org/2025/09/29/copper-64cu-adarulatide-tetraxetan/2025-09-29T02:50:32+00:00monthlyhttps://newdrugapprovals.org/2025/09/28/claziprotamide/2025-09-28T02:28:54+00:00monthlyhttps://newdrugapprovals.org/2025/09/27/camibirstat/2025-09-27T05:28:41+00:00monthlyhttps://newdrugapprovals.org/2025/09/27/pharma-eurasia-2026-supported-by-ministry-of-health-republic-of-uzbekistan/https://newdrugapprovals.org/wp-content/uploads/2025/09/str1-2.jpgSTR12025-09-27T03:14:16+00:00monthlyhttps://newdrugapprovals.org/2025/09/27/spsr-excellence-award-2025-spsr-global-pharmacist-excellence-awards-2025/https://newdrugapprovals.org/wp-content/uploads/2025/09/str1-1.jpgSTR12025-09-27T03:06:43+00:00monthlyhttps://newdrugapprovals.org/2025/09/26/brimarafenib/2025-09-26T02:31:31+00:00monthlyhttps://newdrugapprovals.org/2025/09/25/brezivaptan/2025-09-25T02:53:54+00:00monthlyhttps://newdrugapprovals.org/2025/09/24/atumelnant/2025-09-24T02:51:01+00:00monthlyhttps://newdrugapprovals.org/2025/09/23/ateganosine/2025-09-23T05:46:44+00:00monthlyhttps://newdrugapprovals.org/2025/09/22/bimokalner/2025-09-22T03:00:38+00:00monthlyhttps://newdrugapprovals.org/2025/09/21/asengeprast/2025-09-21T09:38:56+00:00monthlyhttps://newdrugapprovals.org/2025/09/21/asandeutertinib/2025-09-21T02:49:41+00:00monthlyhttps://newdrugapprovals.org/2025/09/20/admilparant/2025-09-20T09:53:04+00:00monthlyhttps://newdrugapprovals.org/2025/09/17/fexuprazan-abeprazan/2025-09-17T02:37:54+00:00monthlyhttps://newdrugapprovals.org/2025/09/15/atigliflozin/2025-09-15T09:58:11+00:00monthlyhttps://newdrugapprovals.org/2025/09/06/niper-g-and-ndtl-collaborate-to-synthesize-methandienone-long-term-metabolite-for-global-anti-doping-efforts/https://newdrugapprovals.org/wp-content/uploads/2025/09/str1.jpgSTR12025-09-14T02:17:04+00:00monthlyhttps://newdrugapprovals.org/2025/09/13/abarelix/2025-09-13T02:43:26+00:00monthlyhttps://newdrugapprovals.org/2020/09/27/abametapir-%e3%82%a2%e3%83%90%e3%83%a1%e3%82%bf%e3%83%94%e3%83%ab-%d0%b0%d0%b1%d0%b0%d0%bc%d0%b5%d1%82%d0%b0%d0%bf%d0%b8%d1%80-%d8%a3%d8%a8%d8%a7%d9%85%d9%8a%d8%aa%d8%a7%d8%a8%d9%8a%d8%b1/https://newdrugapprovals.org/wp-content/uploads/2020/09/str1-2.jpgSTR1https://newdrugapprovals.org/wp-content/uploads/2020/09/str2.jpgSTR2https://newdrugapprovals.org/wp-content/uploads/2020/09/str1-1.jpgSTR1https://newdrugapprovals.org/wp-content/uploads/2020/09/image-1.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2020/09/image.pngimage2025-09-13T02:22:04+00:00monthlyhttps://newdrugapprovals.org/2021/07/19/rilzabrutinib/https://newdrugapprovals.org/wp-content/uploads/2021/07/image-3.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2021/07/image-2.pngimage2025-09-12T02:31:47+00:00monthlyhttps://newdrugapprovals.org/2025/09/11/rongliflozin-olorigliflozin/2025-09-11T05:47:49+00:00monthlyhttps://newdrugapprovals.org/2025/09/10/mizagliflozin/2025-09-10T02:57:29+00:00monthlyhttps://newdrugapprovals.org/2016/04/16/henagliflozin/https://newdrugapprovals.org/wp-content/uploads/2016/04/str1-2.jpgSTR1https://newdrugapprovals.org/wp-content/uploads/2016/04/str1-1.jpgSTR12025-09-09T02:39:53+00:00monthlyhttps://newdrugapprovals.org/2025/08/25/janagliflozin/https://newdrugapprovals.org/wp-content/uploads/2025/08/str1-3.jpgSTR12025-09-08T03:16:44+00:00monthlyhttps://newdrugapprovals.org/2025/09/06/ebselen/2025-09-06T14:30:15+00:00monthlyhttps://newdrugapprovals.org/2025/09/04/sergliflozin-etabonate/2025-09-04T06:09:47+00:00monthlyhttps://newdrugapprovals.org/2015/10/12/sparsentan-ps433540-re-021/https://newdrugapprovals.org/wp-content/uploads/2015/10/str1-5.jpgSTR1https://newdrugapprovals.org/wp-content/uploads/2015/10/str1-4.jpgSTR12025-09-04T02:50:39+00:00monthlyhttps://newdrugapprovals.org/2025/09/03/donidalorsen/2025-09-03T02:15:00+00:00monthlyhttps://newdrugapprovals.org/2016/10/04/vadadustat/https://newdrugapprovals.org/wp-content/uploads/2016/10/str1.jpgSTR1https://newdrugapprovals.org/wp-content/uploads/2016/10/65dc0-str3.jpg65dc0-str3https://newdrugapprovals.org/wp-content/uploads/2016/10/34d80-str4.jpg34d80-str4https://newdrugapprovals.org/wp-content/uploads/2016/10/1aac1-str5.jpg1aac1-str5https://newdrugapprovals.org/wp-content/uploads/2016/10/6ae25-str6.jpg6ae25-str6https://newdrugapprovals.org/wp-content/uploads/2016/10/30e4b-str7.jpg30e4b-str7https://newdrugapprovals.org/wp-content/uploads/2016/10/bc05c-str1.jpgbc05c-str1https://newdrugapprovals.org/wp-content/uploads/2016/10/12fa0-str2.jpg12fa0-str22025-09-01T03:24:13+00:00monthlyhttps://newdrugapprovals.org/2025/08/31/baxdrostat/2025-08-31T09:44:11+00:00monthlyhttps://newdrugapprovals.org/2014/08/07/momelotinib-selective-jak2-inhibitor/https://newdrugapprovals.org/wp-content/uploads/2014/08/str1.jpgSTR12025-08-30T09:27:56+00:00monthlyhttps://newdrugapprovals.org/2025/05/23/durlobactam/https://newdrugapprovals.org/wp-content/uploads/2025/05/str1-8.jpgSTR1https://newdrugapprovals.org/wp-content/uploads/2025/05/str1-1.jpgSTR1https://newdrugapprovals.org/wp-content/uploads/2025/05/image.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2025/05/str1.jpgSTR12025-08-30T09:02:42+00:00monthlyhttps://newdrugapprovals.org/2025/08/30/linaprazan/2025-08-30T02:57:43+00:00monthlyhttps://newdrugapprovals.org/2025/08/29/pradefovir/2025-08-29T02:49:55+00:00monthlyhttps://newdrugapprovals.org/2020/02/26/enavogliflozin-dwp-16001/https://newdrugapprovals.org/wp-content/uploads/2020/02/str1-3.jpgSTR1https://newdrugapprovals.org/wp-content/uploads/2020/02/str2.jpgSTR2https://newdrugapprovals.org/wp-content/uploads/2020/02/str1-2.jpgSTR12025-08-28T10:19:00+00:00monthlyhttps://newdrugapprovals.org/2025/08/28/bevifibatide/2025-08-28T02:53:32+00:00monthlyhttps://newdrugapprovals.org/2023/12/17/iptacopan/https://newdrugapprovals.org/wp-content/uploads/2023/12/image.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2023/12/wdt.jpgwdt2025-08-28T02:28:33+00:00monthlyhttps://newdrugapprovals.org/2025/08/27/tegileridine/2025-08-27T10:42:53+00:00monthlyhttps://newdrugapprovals.org/2025/08/27/velagliflozin/2025-08-27T02:37:44+00:00monthlyhttps://newdrugapprovals.org/2025/08/26/cetagliptin/2025-08-26T03:19:41+00:00monthlyhttps://newdrugapprovals.org/2017/01/23/fotagliptin/https://newdrugapprovals.org/wp-content/uploads/2017/01/str1.jpgSTR12025-08-26T02:45:36+00:00monthlyhttps://newdrugapprovals.org/2025/08/25/cofrogliptin/2025-08-25T08:44:21+00:00monthlyhttps://newdrugapprovals.org/2025/06/30/taletrectinib/https://newdrugapprovals.org/wp-content/uploads/2025/06/str1-3.jpgSTR12025-08-24T05:08:35+00:00monthlyhttps://newdrugapprovals.org/2025/08/21/zorifertinib/2025-08-21T04:15:36+00:00monthlyhttps://newdrugapprovals.org/2025/08/20/garsorasib/2025-08-20T10:30:19+00:00monthlyhttps://newdrugapprovals.org/2025/08/20/fulzerasib/2025-08-20T05:15:26+00:00monthlyhttps://newdrugapprovals.org/2025/08/19/golidocitinib/2025-08-19T02:36:21+00:00monthlyhttps://newdrugapprovals.org/2025/08/18/oritinib/2025-08-18T02:40:30+00:00monthlyhttps://newdrugapprovals.org/2025/08/17/envonalkib/https://newdrugapprovals.org/wp-content/uploads/2025/08/str1-2.jpgSTR12025-08-17T06:04:43+00:00monthlyhttps://newdrugapprovals.org/2025/08/17/brensocatib/2025-08-17T02:31:57+00:00monthlyhttps://newdrugapprovals.org/2021/07/03/23965/https://newdrugapprovals.org/wp-content/uploads/2021/07/str1-2.jpgSTR12025-08-16T02:47:26+00:00monthlyhttps://newdrugapprovals.org/2025/08/08/ropotrectinib/https://newdrugapprovals.org/wp-content/uploads/2025/08/str1-1.jpgSTR12025-08-16T02:30:46+00:00monthlyhttps://newdrugapprovals.org/2025/08/15/unecritinib/2025-08-15T11:06:15+00:00monthlyhttps://newdrugapprovals.org/2015/01/09/entinostat/https://newdrugapprovals.org/wp-content/uploads/2015/01/str1-1.jpgSTR1https://newdrugapprovals.org/wp-content/uploads/2015/01/str1.jpgSTR12025-08-15T02:49:14+00:00monthlyhttps://newdrugapprovals.org/2025/08/14/dordaviprone/2025-08-14T10:13:31+00:00monthlyhttps://newdrugapprovals.org/2025/08/14/tunlametinib/2025-08-14T06:14:02+00:00monthlyhttps://newdrugapprovals.org/2021/06/05/ibrexafungerp-citrate/https://newdrugapprovals.org/wp-content/uploads/2021/06/image.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2021/06/str1-2.jpgSTR1https://newdrugapprovals.org/wp-content/uploads/2021/06/str1-1.jpgSTR1https://newdrugapprovals.org/wp-content/uploads/2021/06/str1.jpgSTR12025-08-11T08:15:45+00:00monthlyhttps://newdrugapprovals.org/2025/08/11/befotertinib/2025-08-11T02:38:22+00:00monthlyhttps://newdrugapprovals.org/2025/08/10/iruplinalkib/2025-08-10T08:57:40+00:00monthlyhttps://newdrugapprovals.org/2025/08/10/zongertinib/2025-08-10T02:44:25+00:00monthlyhttps://newdrugapprovals.org/2022/08/30/lenacapavir-sodium/2025-08-09T11:33:36+00:00monthlyhttps://newdrugapprovals.org/2025/08/09/aceclidine/2025-08-09T02:25:26+00:00monthlyhttps://newdrugapprovals.org/2022/01/18/taurolidine/https://newdrugapprovals.org/wp-content/uploads/2022/01/str1-19.jpgSTR12025-08-05T02:48:47+00:00monthlyhttps://newdrugapprovals.org/2022/01/27/gefapixant-citrate/https://newdrugapprovals.org/wp-content/uploads/2022/01/str1-18.jpgSTR12025-08-05T02:36:35+00:00monthlyhttps://newdrugapprovals.org/2025/08/04/donafenib/2025-08-04T09:50:53+00:00monthlyhttps://newdrugapprovals.org/2025/08/03/pamiparib/https://newdrugapprovals.org/wp-content/uploads/2025/08/str1.jpgSTR12025-08-04T09:29:36+00:00monthlyhttps://newdrugapprovals.org/2025/08/03/sepiapterin/2025-08-03T03:19:43+00:00monthlyhttps://newdrugapprovals.org/2025/07/30/olverembatinib/2025-07-30T06:29:43+00:00monthlyhttps://newdrugapprovals.org/2025/07/29/dorzagliatin/2025-07-29T02:48:54+00:00monthlyhttps://newdrugapprovals.org/2025/07/28/chiglitazar/2025-07-28T08:39:38+00:00monthlyhttps://newdrugapprovals.org/2020/02/06/delgocitinib/https://newdrugapprovals.org/wp-content/uploads/2020/02/str1-1.jpgSTR1https://newdrugapprovals.org/wp-content/uploads/2020/02/str1.jpgSTR12025-07-26T03:05:10+00:00monthlyhttps://newdrugapprovals.org/2022/03/21/ganaxolone/https://newdrugapprovals.org/wp-content/uploads/2022/03/str1-6.jpgSTR12025-07-26T02:38:02+00:00monthlyhttps://newdrugapprovals.org/2025/07/25/27444/2025-07-25T10:57:45+00:00monthlyhttps://newdrugapprovals.org/2021/02/17/trofinetide/https://newdrugapprovals.org/wp-content/uploads/2021/02/str1-2.jpgSTR1https://newdrugapprovals.org/wp-content/uploads/2021/02/image.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2021/02/str1-1.jpgSTR12025-07-25T03:14:52+00:00monthlyhttps://newdrugapprovals.org/2023/08/22/palovarotene/https://newdrugapprovals.org/wp-content/uploads/2023/08/str1-1.jpgSTR1https://newdrugapprovals.org/wp-content/uploads/2023/08/str1.jpgSTR1https://newdrugapprovals.org/wp-content/uploads/2023/08/image-1.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2023/08/wdt.jpgwdt2025-07-25T02:58:47+00:00monthlyhttps://newdrugapprovals.org/2025/07/24/tebapivat/2025-07-24T02:56:42+00:00monthlyhttps://newdrugapprovals.org/2019/06/08/mitapivat/https://newdrugapprovals.org/wp-content/uploads/2019/06/str1.jpgSTR12025-07-23T08:13:47+00:00monthlyhttps://newdrugapprovals.org/2025/07/23/tagtociclib/2025-07-23T02:49:54+00:00monthlyhttps://newdrugapprovals.org/2018/06/25/mavacamten/https://newdrugapprovals.org/wp-content/uploads/2018/06/str1.jpgSTR12025-07-22T08:15:26+00:00monthlyhttps://newdrugapprovals.org/2024/01/10/tacaciclib-aur-102-aurigene/https://newdrugapprovals.org/wp-content/uploads/2024/01/str1-1.pngSTR1https://newdrugapprovals.org/wp-content/uploads/2024/01/str1.pngSTR1https://newdrugapprovals.org/wp-content/uploads/2024/01/wdt.jpgwdt2025-07-22T02:37:49+00:00monthlyhttps://newdrugapprovals.org/2025/07/22/spirobudifen/2025-07-22T02:21:55+00:00monthlyhttps://newdrugapprovals.org/2025/07/21/hetrombopag-olamine/https://newdrugapprovals.org/wp-content/uploads/2025/07/str1.jpgSTR12025-07-21T08:48:40+00:00monthlyhttps://newdrugapprovals.org/2025/07/21/sovesudil/2025-07-21T02:47:40+00:00monthlyhttps://newdrugapprovals.org/2024/02/01/sotuletinib-hcl/https://newdrugapprovals.org/wp-content/uploads/2024/02/str1-10.pngSTR12025-07-20T13:43:50+00:00monthlyhttps://newdrugapprovals.org/2021/07/29/oteseconazole/https://newdrugapprovals.org/wp-content/uploads/2021/07/str1-1.jpgSTR1https://newdrugapprovals.org/wp-content/uploads/2021/07/str1.jpgSTR1https://newdrugapprovals.org/wp-content/uploads/2022/05/image.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2022/05/str1-2.jpgstr1-2https://newdrugapprovals.org/wp-content/uploads/2022/05/str1-1.jpgstr1-1https://newdrugapprovals.org/wp-content/uploads/2022/05/str1.jpgstr12025-07-20T10:21:55+00:00monthlyhttps://newdrugapprovals.org/2025/07/20/contezolid/2025-07-20T03:10:08+00:00monthlyhttps://newdrugapprovals.org/2022/03/04/ensitrelvir/https://newdrugapprovals.org/wp-content/uploads/2022/03/str1-5.jpgSTR1https://newdrugapprovals.org/wp-content/uploads/2022/03/str1-4.jpgSTR12025-07-20T02:46:01+00:00monthlyhttps://newdrugapprovals.org/2025/07/19/azvudine/2025-07-19T05:39:42+00:00monthlyhttps://newdrugapprovals.org/2025/05/12/omaveloxolone/https://newdrugapprovals.org/wp-content/uploads/2025/05/str1-7.jpgSTR1https://newdrugapprovals.org/wp-content/uploads/2025/05/image-1.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2025/05/str1-6.jpgSTR12025-07-18T08:09:43+00:00monthlyhttps://newdrugapprovals.org/2025/07/18/sontigidomide/2025-07-18T02:53:28+00:00monthlyhttps://newdrugapprovals.org/2025/05/16/leniolisib/https://newdrugapprovals.org/wp-content/uploads/2025/05/str1-5.jpgSTR1https://newdrugapprovals.org/wp-content/uploads/2025/05/str1-4.jpgSTR12025-07-17T08:19:42+00:00monthlyhttps://newdrugapprovals.org/2021/04/11/serdexmethylphenidate/https://newdrugapprovals.org/wp-content/uploads/2021/04/image.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2021/04/str1.pngSTR12025-07-17T02:54:09+00:00monthlyhttps://newdrugapprovals.org/2015/10/05/bexagliflozin/https://newdrugapprovals.org/wp-content/uploads/2015/10/str1-3.jpgSTR1https://newdrugapprovals.org/wp-content/uploads/2015/10/image.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2015/10/str1-2.jpgSTR1https://newdrugapprovals.org/wp-content/uploads/2015/10/str1-1.jpgSTR1https://newdrugapprovals.org/wp-content/uploads/2015/10/im1.pngim12025-07-16T09:13:47+00:00monthlyhttps://newdrugapprovals.org/2025/07/16/keverprazan/https://newdrugapprovals.org/wp-content/uploads/2025/07/image-2.pngimage2025-07-16T09:12:10+00:00monthlyhttps://newdrugapprovals.org/2021/11/11/rp-12146/https://newdrugapprovals.org/wp-content/uploads/2021/11/image-2.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2021/11/str1.pngSTR1https://newdrugapprovals.org/wp-content/uploads/2021/11/image-1.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2021/11/image.pngimage2025-07-16T02:30:17+00:00monthlyhttps://newdrugapprovals.org/2025/05/22/sulbactam/https://newdrugapprovals.org/wp-content/uploads/2025/05/str1-2.jpgSTR12025-07-15T08:07:55+00:00monthlyhttps://newdrugapprovals.org/2025/07/15/risevistinel/https://newdrugapprovals.org/wp-content/uploads/2025/07/image-1.pngimage2025-07-15T02:56:03+00:00monthlyhttps://newdrugapprovals.org/2025/05/15/rezafungin/https://newdrugapprovals.org/wp-content/uploads/2025/05/str1-3.jpgSTR12025-07-14T06:13:26+00:00monthlyhttps://newdrugapprovals.org/2025/07/14/rezatapopt/2025-07-14T03:08:29+00:00monthlyhttps://newdrugapprovals.org/2025/07/13/resigratinib/2025-07-13T02:44:29+00:00monthlyhttps://newdrugapprovals.org/2025/07/11/sebetralstat/2025-07-11T06:13:26+00:00monthlyhttps://newdrugapprovals.org/2025/07/11/redafamdastat/2025-07-11T02:46:52+00:00monthlyhttps://newdrugapprovals.org/2016/01/23/what-was-the-drug-in-clinical-trial-tragedy-in-france-jan-2016/2025-07-11T02:20:06+00:00monthlyhttps://newdrugapprovals.org/2025/07/10/arazasetron-besylate/2025-07-10T09:40:52+00:00monthlyhttps://newdrugapprovals.org/2025/07/10/sunvozertinib/https://newdrugapprovals.org/wp-content/uploads/2025/07/wdt-4.jpgWDT2025-07-10T09:22:32+00:00monthlyhttps://newdrugapprovals.org/2025/07/09/pritelivir-mesylate/https://newdrugapprovals.org/wp-content/uploads/2025/07/wdt-3.jpgWDThttps://newdrugapprovals.org/wp-content/uploads/2025/07/wdt-2.jpgWDT2025-07-10T09:20:46+00:00monthlyhttps://newdrugapprovals.org/2025/07/08/pimicotinib/https://newdrugapprovals.org/wp-content/uploads/2025/07/wdt-1.jpgWDThttps://newdrugapprovals.org/wp-content/uploads/2025/07/image.pngimage2025-07-08T03:02:24+00:00monthlyhttps://newdrugapprovals.org/2025/07/05/palazestrant/2025-07-05T08:28:35+00:00monthlyhttps://newdrugapprovals.org/2024/02/01/orziloben/https://newdrugapprovals.org/wp-content/uploads/2024/02/image-4.pngimage2025-07-04T05:36:13+00:00monthlyhttps://newdrugapprovals.org/2025/07/02/orforglipron/2025-07-02T08:25:34+00:00monthlyhttps://newdrugapprovals.org/2024/02/01/opevesostat/https://newdrugapprovals.org/wp-content/uploads/2024/02/str1-9.pngSTR12025-07-01T02:47:46+00:00monthlyhttps://newdrugapprovals.org/2015/03/02/atrasentan-revisited/2025-06-30T05:56:18+00:00monthlyhttps://newdrugapprovals.org/2025/06/29/olgotrelvir/https://newdrugapprovals.org/wp-content/uploads/2025/06/image-4.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2025/06/image-3.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2025/06/image-2.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2025/06/image-1.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2025/06/str1-2.jpgSTR12025-06-29T02:48:33+00:00monthlyhttps://newdrugapprovals.org/2024/02/01/oditrasertib/https://newdrugapprovals.org/wp-content/uploads/2024/02/image-3.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2024/02/str1-8.pngSTR12025-06-28T02:55:10+00:00monthlyhttps://newdrugapprovals.org/2025/06/26/nerigliatin/https://newdrugapprovals.org/wp-content/uploads/2025/06/wdt.jpgWDThttps://newdrugapprovals.org/wp-content/uploads/2025/06/image.pngimage2025-06-28T02:45:22+00:00monthlyhttps://newdrugapprovals.org/2024/02/01/oditrasertib-2/https://newdrugapprovals.org/wp-content/uploads/2024/02/image-2.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2024/02/str1-7.pngSTR1https://newdrugapprovals.org/wp-content/uploads/2024/02/str1-6.pngSTR12025-06-28T02:37:16+00:00monthlyhttps://newdrugapprovals.org/2025/06/27/acoltremon/2025-06-27T02:43:47+00:00monthlyhttps://newdrugapprovals.org/2015/11/27/pfizers-pf-04937319-glucokinase-activators-for-the-treatment-of-type-2-diabetes/https://newdrugapprovals.org/wp-content/uploads/2015/11/pf-319-syn.pngPF 319 SYN2025-06-26T02:29:20+00:00monthlyhttps://newdrugapprovals.org/2025/06/24/nemorexant-2/2025-06-24T02:40:34+00:00monthlyhttps://newdrugapprovals.org/2018/11/16/nemorexant/https://newdrugapprovals.org/wp-content/uploads/2018/11/str1.pngSTR12025-06-24T02:39:15+00:00monthlyhttps://newdrugapprovals.org/2025/06/23/nedometinib/2025-06-23T02:41:45+00:00monthlyhttps://newdrugapprovals.org/2025/06/22/modoflaner/2025-06-22T02:34:19+00:00monthlyhttps://newdrugapprovals.org/2025/06/21/mivorilaner/2025-06-21T02:36:57+00:00monthlyhttps://newdrugapprovals.org/2025/06/20/mirdametinib-2/2025-06-20T02:36:49+00:00monthlyhttps://newdrugapprovals.org/2021/07/31/mirdametinib/https://newdrugapprovals.org/wp-content/uploads/2021/07/str1-1.pngSTR1https://newdrugapprovals.org/wp-content/uploads/2021/07/str1.pngSTR1https://newdrugapprovals.org/wp-content/uploads/2021/07/image-1.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2021/07/image.pngimage2025-06-20T02:34:45+00:00monthlyhttps://newdrugapprovals.org/2022/10/21/milademetan/https://newdrugapprovals.org/wp-content/uploads/2022/10/wdt-5.jpgwdt-52025-06-20T02:26:51+00:00monthlyhttps://newdrugapprovals.org/2025/06/20/milademetan-2/2025-06-20T02:25:12+00:00monthlyhttps://newdrugapprovals.org/2025/06/19/levalbuterol-tartrate/2025-06-19T02:36:17+00:00monthlyhttps://newdrugapprovals.org/2025/06/16/zilucoplan/2025-06-16T02:45:16+00:00monthlyhttps://newdrugapprovals.org/2025/06/15/labuxtinib/2025-06-15T03:05:40+00:00monthlyhttps://newdrugapprovals.org/2024/02/01/inaxaplin/https://newdrugapprovals.org/wp-content/uploads/2024/02/str1-5.pngSTR12025-06-13T02:49:09+00:00monthlyhttps://newdrugapprovals.org/2025/06/13/inaxaplin-2/2025-06-13T02:46:36+00:00monthlyhttps://newdrugapprovals.org/2025/06/12/gepirone/2025-06-12T03:06:10+00:00monthlyhttps://newdrugapprovals.org/2025/06/11/igermetostat-2/2025-06-11T02:36:59+00:00monthlyhttps://newdrugapprovals.org/2024/02/01/igermetostat/https://newdrugapprovals.org/wp-content/uploads/2024/02/str1-4.pngSTR1https://newdrugapprovals.org/wp-content/uploads/2024/02/image-1.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2024/02/str1-3.pngSTR12025-06-11T02:35:47+00:00monthlyhttps://newdrugapprovals.org/2025/06/10/hexasodium-phytate/2025-06-10T03:04:16+00:00monthlyhttps://newdrugapprovals.org/2025/06/09/ibuzatrelvir/2025-06-09T03:08:13+00:00monthlyhttps://newdrugapprovals.org/2025/06/07/golcadomide-cc-99282-2/2025-06-07T09:01:01+00:00monthlyhttps://newdrugapprovals.org/2024/02/01/golcadomide-cc-99282/https://newdrugapprovals.org/wp-content/uploads/2024/02/str1-2.pngSTR1https://newdrugapprovals.org/wp-content/uploads/2024/02/str1-1.pngSTR1https://newdrugapprovals.org/wp-content/uploads/2024/02/str1.pngSTR12025-06-07T08:59:38+00:00monthlyhttps://newdrugapprovals.org/2025/06/06/gamcemetinib/2025-06-06T03:05:06+00:00monthlyhttps://newdrugapprovals.org/2025/06/03/alflutinib-furmonertinib-firmonertinib/2025-06-03T03:09:11+00:00monthlyhttps://newdrugapprovals.org/2022/10/11/firibastat/https://newdrugapprovals.org/wp-content/uploads/2022/10/str1.pngSTR12025-06-02T10:08:01+00:00monthlyhttps://newdrugapprovals.org/2025/06/02/firibastat-2/2025-06-02T10:07:26+00:00monthlyhttps://newdrugapprovals.org/scientificupdate-uk-on-a-roll/https://newdrugapprovals.org/wp-content/uploads/2025/06/str1-1.jpgSTR1https://newdrugapprovals.org/wp-content/uploads/2025/06/str1.jpgSTR12025-06-01T03:33:36+00:00weekly0.6https://newdrugapprovals.org/2025/05/31/lotilaner/2025-05-31T02:58:22+00:00monthlyhttps://newdrugapprovals.org/2019/07/03/quizartinib-dihydrochloride-%e3%82%ad%e3%82%b6%e3%83%ab%e3%83%81%e3%83%8b%e3%83%96%e5%a1%a9%e9%85%b8%e5%a1%a9/2025-05-31T02:38:23+00:00monthlyhttps://newdrugapprovals.org/2025/05/30/fexagratinib/2025-05-30T02:59:04+00:00monthlyhttps://newdrugapprovals.org/2025/05/29/gdc-0853-fenebrutinib/2025-05-29T11:14:44+00:00monthlyhttps://newdrugapprovals.org/2016/03/30/gdc-0853/https://newdrugapprovals.org/wp-content/uploads/2016/03/str1-2.pngSTR1https://newdrugapprovals.org/wp-content/uploads/2016/03/str1-1.pngSTR1https://newdrugapprovals.org/wp-content/uploads/2016/03/c018b-strucutre.pngc018b-strucutre2025-05-29T11:12:49+00:00monthlyhttps://newdrugapprovals.org/2025/04/03/suzetrigine/https://newdrugapprovals.org/wp-content/uploads/2025/04/image-12.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2025/04/image-11.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2025/04/image-10.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2025/04/image-9.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2025/04/image-8.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2025/04/image-7.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2025/04/image-6.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2025/04/image-5.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2025/04/image-4.pngimage2025-05-29T03:13:27+00:00monthlyhttps://newdrugapprovals.org/2025/05/29/ritlecitinib-pf-06651600/2025-05-29T03:02:53+00:00monthlyhttps://newdrugapprovals.org/2019/08/05/pf-06651600/2025-05-28T10:56:10+00:00monthlyhttps://newdrugapprovals.org/2025/05/27/ervogastat/2025-05-27T03:04:35+00:00monthlyhttps://newdrugapprovals.org/2025/05/26/flotufolastat-f-18/2025-05-26T13:30:49+00:00monthlyhttps://newdrugapprovals.org/2022/10/01/enobosarm/2025-05-26T05:59:45+00:00monthlyhttps://newdrugapprovals.org/2025/05/25/elubiol/2025-05-25T02:57:08+00:00monthlyhttps://newdrugapprovals.org/2025/05/24/elfucose/2025-05-24T02:59:03+00:00monthlyhttps://newdrugapprovals.org/2025/05/23/edelinontrine/2025-05-23T03:04:07+00:00monthlyhttps://newdrugapprovals.org/2025/05/22/eclitasertib/2025-05-22T03:13:08+00:00monthlyhttps://newdrugapprovals.org/2025/05/21/perfluorhexyloctane/2025-05-21T02:49:35+00:00monthlyhttps://newdrugapprovals.org/2025/05/20/dimdazenil/2025-05-20T09:16:08+00:00monthlyhttps://newdrugapprovals.org/2019/01/30/fezolinetant-%d1%84%d0%b5%d0%b7%d0%be%d0%bb%d0%b8%d0%bd%d0%b5%d1%82%d0%b0%d0%bd%d1%82-%d9%81%d9%8a%d8%b2%d9%88%d9%84%d9%8a%d9%86%d9%8a%d8%aa%d8%a7%d9%86%d8%aa-%e9%9d%9e%e5%94%91%e5%a5%88%e5%9d%a6/2025-05-19T09:03:14+00:00monthlyhttps://newdrugapprovals.org/2025/05/19/digadoglucitol/2025-05-19T02:51:21+00:00monthlyhttps://newdrugapprovals.org/2025/05/17/tofersen/2025-05-17T09:23:29+00:00monthlyhttps://newdrugapprovals.org/2025/05/17/26861/2025-05-17T02:58:23+00:00monthlyhttps://newdrugapprovals.org/2025/05/16/26858/2025-05-16T10:23:31+00:00monthlyhttps://newdrugapprovals.org/2025/05/15/dazdotuftide/2025-05-15T06:18:46+00:00monthlyhttps://newdrugapprovals.org/2025/05/14/davelizomib/2025-05-14T08:56:37+00:00monthlyhttps://newdrugapprovals.org/2025/05/11/dasminapant/2025-05-11T13:20:04+00:00monthlyhttps://newdrugapprovals.org/2025/05/10/crisugabalin/2025-05-10T10:00:18+00:00monthlyhttps://newdrugapprovals.org/2025/05/10/elacestrant/2025-05-10T02:51:35+00:00monthlyhttps://newdrugapprovals.org/2025/05/09/clofutriben/2025-05-09T13:16:46+00:00monthlyhttps://newdrugapprovals.org/2025/05/09/pirtobrutinib/2025-05-09T03:16:41+00:00monthlyhttps://newdrugapprovals.org/2025/05/08/clesacostat/2025-05-08T09:05:52+00:00monthlyhttps://newdrugapprovals.org/2025/05/07/civorebrutinib/2025-05-07T09:05:48+00:00monthlyhttps://newdrugapprovals.org/2025/05/05/cinsebrutinib/2025-05-05T10:50:16+00:00monthlyhttps://newdrugapprovals.org/2016/08/25/rpl-554/2025-05-05T10:19:26+00:00monthlyhttps://newdrugapprovals.org/2024/09/07/lazertinib/2025-05-05T10:10:07+00:00monthlyhttps://newdrugapprovals.org/2019/07/08/ceralasertib-azd-6738/2025-05-04T09:29:55+00:00monthlyhttps://newdrugapprovals.org/2022/05/30/arimoclomol/https://newdrugapprovals.org/wp-content/uploads/2022/05/str1-5.gifstr1-5https://newdrugapprovals.org/wp-content/uploads/2022/05/str1-4.gifstr1-4https://newdrugapprovals.org/wp-content/uploads/2022/05/str1-3.gifstr1-3https://newdrugapprovals.org/wp-content/uploads/2022/05/str1-2.gifstr1-2https://newdrugapprovals.org/wp-content/uploads/2022/05/str1-1.gifstr1-1https://newdrugapprovals.org/wp-content/uploads/2022/05/str1.gifstr1https://newdrugapprovals.org/wp-content/uploads/2022/05/str1-6.jpgstr1-6https://newdrugapprovals.org/wp-content/uploads/2022/05/str4-1.jpgstr4-1https://newdrugapprovals.org/wp-content/uploads/2022/05/str3-1.jpgstr3-1https://newdrugapprovals.org/wp-content/uploads/2022/05/str2-1.jpgstr2-12025-05-04T02:43:46+00:00monthlyhttps://newdrugapprovals.org/2025/05/02/cefilavancin/2025-05-02T09:01:33+00:00monthlyhttps://newdrugapprovals.org/2025/05/01/levacetylleucine/2025-05-01T06:17:21+00:00monthlyhttps://newdrugapprovals.org/2025/04/30/canlitinib/2025-04-30T13:07:01+00:00monthlyhttps://newdrugapprovals.org/2025/04/28/brigimadlin/2025-04-28T09:04:03+00:00monthlyhttps://newdrugapprovals.org/2025/04/28/trospium-chloride/2025-04-28T02:44:04+00:00monthlyhttps://newdrugapprovals.org/2017/09/26/xanomeline-ly-246708-lumeron-memcor-%d0%ba%d1%81%d0%b0%d0%bd%d0%be%d0%bc%d0%b5%d0%bb%d0%b8%d0%bd-%d9%83%d8%b3%d8%a7%d9%86%d9%88%d9%85%d9%8a%d9%84%d9%8a%d9%86-%ee%80%82%e8%af%ba%e7%be%8e/https://newdrugapprovals.org/wp-content/uploads/2017/09/817eb-1442000959856.png817eb-14420009598562025-04-28T02:26:27+00:00monthlyhttps://newdrugapprovals.org/2025/04/27/flurpiridaz-f-18/2025-04-27T09:01:19+00:00monthlyhttps://newdrugapprovals.org/2025/04/27/bofutrelvir/2025-04-27T03:00:57+00:00monthlyhttps://newdrugapprovals.org/2025/04/26/inavolisib/2025-04-26T06:31:56+00:00monthlyhttps://newdrugapprovals.org/2025/04/25/bocodepsin/2025-04-25T09:25:25+00:00monthlyhttps://newdrugapprovals.org/2025/04/25/vanzacaftor/2025-04-25T02:51:18+00:00monthlyhttps://newdrugapprovals.org/2025/04/24/tegeprotafib/2025-04-24T06:23:07+00:00monthlyhttps://newdrugapprovals.org/2025/04/24/probenecid/2025-04-24T03:04:39+00:00monthlyhttps://newdrugapprovals.org/2025/04/23/sulopenem/2025-04-23T02:49:49+00:00monthlyhttps://newdrugapprovals.org/2025/04/22/bleximenib/https://newdrugapprovals.org/wp-content/uploads/2025/04/str1.jpgSTR1https://newdrugapprovals.org/wp-content/uploads/2025/04/image-3.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2025/04/image-2.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2025/04/image-1.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2025/04/image.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2025/04/str1-1.pngSTR1https://newdrugapprovals.org/wp-content/uploads/2025/04/str1.pngSTR12025-04-22T10:29:53+00:00monthlyhttps://newdrugapprovals.org/2025/04/22/revumenib/2025-04-22T02:55:41+00:00monthlyhttps://newdrugapprovals.org/2025/04/21/acoramidis/2025-04-21T10:03:05+00:00monthlyhttps://newdrugapprovals.org/2025/04/21/tegomil-fumarate/2025-04-21T02:42:55+00:00monthlyhttps://newdrugapprovals.org/2025/04/20/landiolol/2025-04-20T02:58:05+00:00monthlyhttps://newdrugapprovals.org/2025/04/19/bivamelagon/2025-04-19T09:03:12+00:00monthlyhttps://newdrugapprovals.org/2025/04/19/iomeprol/2025-04-19T02:53:58+00:00monthlyhttps://newdrugapprovals.org/2025/04/18/crinecerfont/2025-04-18T11:42:18+00:00monthlyhttps://newdrugapprovals.org/2025/04/16/bezisterim-he-3286-ne-3107/2025-04-16T10:37:44+00:00monthlyhttps://newdrugapprovals.org/2025/04/16/ensartinib/2025-04-16T02:53:57+00:00monthlyhttps://newdrugapprovals.org/2025/04/15/bexicaserin/2025-04-15T02:55:13+00:00monthlyhttps://newdrugapprovals.org/2025/04/14/olezarsen/2025-04-14T02:48:04+00:00monthlyhttps://newdrugapprovals.org/2025/04/12/fitusiran/2025-04-12T05:51:50+00:00monthlyhttps://newdrugapprovals.org/2025/04/11/tibremciclib/2025-04-11T08:47:26+00:00monthlyhttps://newdrugapprovals.org/2025/04/10/gepotidacin/2025-04-10T03:20:25+00:00monthlyhttps://newdrugapprovals.org/2025/04/08/vimseltinib/2025-04-08T13:39:53+00:00monthlyhttps://newdrugapprovals.org/2025/04/06/treosulfan/2025-04-06T03:01:12+00:00monthlyhttps://newdrugapprovals.org/2025/04/05/bevemipretide/2025-04-05T03:04:15+00:00monthlyhttps://newdrugapprovals.org/2025/04/02/benzgalantamine/2025-04-02T10:04:06+00:00monthlyhttps://newdrugapprovals.org/2025/04/01/tisolagiline/2025-04-01T03:13:25+00:00monthlyhttps://newdrugapprovals.org/2025/03/30/bemfivastatin-ppd-10558-rbx-10558/2025-03-30T08:33:01+00:00monthlyhttps://newdrugapprovals.org/2025/03/28/umifoxolaner-ml-878/https://newdrugapprovals.org/wp-content/uploads/2025/03/image.pngimage2025-03-28T02:47:20+00:00monthlyhttps://newdrugapprovals.org/2025/03/27/bavtavirine/2025-03-27T05:48:56+00:00monthlyhttps://newdrugapprovals.org/2025/03/25/uplarafenib/2025-03-25T08:13:41+00:00monthlyhttps://newdrugapprovals.org/2022/09/07/zyil-1/https://newdrugapprovals.org/wp-content/uploads/2022/09/str1-1.jpgSTR1https://newdrugapprovals.org/wp-content/uploads/2022/09/str1.jpgSTR1https://newdrugapprovals.org/wp-content/uploads/2024/02/image.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2022/09/wdt-1.jpgwdt-12025-03-25T02:58:41+00:00monthlyhttps://newdrugapprovals.org/2024/10/15/avenciguat/2024-10-15T02:54:59+00:00monthlyhttps://newdrugapprovals.org/2024/10/13/valiltramiprosate/2024-10-13T02:55:52+00:00monthlyhttps://newdrugapprovals.org/2024/10/12/vicatertide/2024-10-12T09:51:09+00:00monthlyhttps://newdrugapprovals.org/2024/10/12/vorbipiprant/2024-10-12T05:16:54+00:00monthlyhttps://newdrugapprovals.org/2024/09/30/atuzaginstat/2024-09-30T03:10:22+00:00monthlyhttps://newdrugapprovals.org/2024/09/23/votoplam/2024-09-23T11:11:47+00:00monthlyhttps://newdrugapprovals.org/2024/09/16/atilotrelvir/2024-09-16T13:41:09+00:00monthlyhttps://newdrugapprovals.org/2024/09/15/zamaporvint/https://newdrugapprovals.org/wp-content/uploads/2024/09/str1.jpgSTR12024-09-15T08:10:27+00:00monthlyhttps://newdrugapprovals.org/2024/09/13/aticaprant/2024-09-13T10:50:21+00:00monthlyhttps://newdrugapprovals.org/2024/09/13/zastaprazan/2024-09-13T06:39:31+00:00monthlyhttps://newdrugapprovals.org/2024/09/11/deuruxolitinib/2024-09-11T06:20:14+00:00monthlyhttps://newdrugapprovals.org/2024/09/11/zelatriazin/2024-09-11T02:50:50+00:00monthlyhttps://newdrugapprovals.org/2024/09/10/vorasidenib/2024-09-10T07:58:55+00:00monthlyhttps://newdrugapprovals.org/2024/09/10/arbemnifosbuvir-at-752-pd160572/2024-09-10T02:37:07+00:00monthlyhttps://newdrugapprovals.org/2024/09/09/zelicapavir/2024-09-09T13:57:15+00:00monthlyhttps://newdrugapprovals.org/2024/09/09/palopegteriparatide/2024-09-09T06:06:35+00:00monthlyhttps://newdrugapprovals.org/2024/09/09/aneratrigine/2024-09-09T06:06:11+00:00monthlyhttps://newdrugapprovals.org/2024/09/08/seladelpar/2024-09-08T08:39:38+00:00monthlyhttps://newdrugapprovals.org/2024/09/08/zevotrelvir-edp-235/2024-09-08T03:12:01+00:00monthlyhttps://newdrugapprovals.org/2024/09/07/afimetoran/https://newdrugapprovals.org/wp-content/uploads/2024/09/str2.jpgSTR2https://newdrugapprovals.org/wp-content/uploads/2024/09/str1.pngSTR12024-09-07T06:07:04+00:00monthlyhttps://newdrugapprovals.org/2024/05/19/act-132577-aprocitentan/2024-05-19T09:08:52+00:00monthlyhttps://newdrugapprovals.org/2024/05/17/cefepime/2024-05-17T06:23:50+00:00monthlyhttps://newdrugapprovals.org/2021/05/23/ocid-5090-enmetazobactam/2024-05-15T05:35:04+00:00monthlyhttps://newdrugapprovals.org/2024/05/14/berdazimer/2024-05-14T08:33:17+00:00monthlyhttps://newdrugapprovals.org/2020/01/14/resmetirom/2024-05-13T09:31:19+00:00monthlyhttps://newdrugapprovals.org/2024/05/10/tovorafenib/2024-05-10T02:51:07+00:00monthlyhttps://newdrugapprovals.org/2023/04/19/mavorixafor/https://newdrugapprovals.org/wp-content/uploads/2023/04/wdt.jpgwdt2024-05-09T02:27:21+00:00monthlyhttps://newdrugapprovals.org/2024/04/15/ceftobiprole/2024-04-15T02:37:22+00:00monthlyhttps://newdrugapprovals.org/2024/04/11/danicopan/https://newdrugapprovals.org/wp-content/uploads/2024/04/str2.jpgstr22024-04-11T10:26:27+00:00monthlyhttps://newdrugapprovals.org/2023/12/25/capivasertib/2023-12-25T02:43:44+00:00monthlyhttps://newdrugapprovals.org/2023/12/24/eplontersen/2023-12-24T11:34:37+00:00monthlyhttps://newdrugapprovals.org/2021/02/23/nirogacestat/2023-12-21T02:26:12+00:00monthlyhttps://newdrugapprovals.org/2023/11/16/carebastine/https://newdrugapprovals.org/wp-content/uploads/2023/11/wdt.jpgwdt2023-11-16T02:40:36+00:00monthlyhttps://newdrugapprovals.org/2023/11/14/vodobatinib/2023-11-14T05:53:10+00:00monthlyhttps://newdrugapprovals.org/2023/10/25/etrasimod/https://newdrugapprovals.org/wp-content/uploads/2023/10/wdt.jpgwdt2023-10-25T02:41:41+00:00monthlyhttps://newdrugapprovals.org/2023/09/21/motixafortide/https://newdrugapprovals.org/wp-content/uploads/2023/09/wdt.jpgwdt2023-09-21T02:54:04+00:00monthlyhttps://newdrugapprovals.org/2023/08/27/evobrutinib/https://newdrugapprovals.org/wp-content/uploads/2023/08/wdt-2.jpgwdt-22023-08-27T09:57:31+00:00monthlyhttps://newdrugapprovals.org/2023/08/26/zuranolone/2023-08-26T12:29:36+00:00monthlyhttps://newdrugapprovals.org/2023/08/23/eidd-2173-ati-2173/https://newdrugapprovals.org/wp-content/uploads/2023/08/image.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2023/08/wdt-1.jpgwdt-12023-08-23T03:07:57+00:00monthlyhttps://newdrugapprovals.org/2023/07/11/zavegepant/https://newdrugapprovals.org/wp-content/uploads/2023/07/wdt.jpgwdt2023-07-11T03:09:57+00:00monthlyhttps://newdrugapprovals.org/2020/01/27/zanubrutinib-%e3%82%b6%e3%83%8c%e3%83%96%e3%83%ab%e3%83%81%e3%83%8b%e3%83%96-%d0%b7%d0%b0%d0%bd%d1%83%d0%b1%d1%80%d1%83%d1%82%d0%b8%d0%bd%d0%b8%d0%b1-%d8%b2%d8%a7%d9%86%d9%88%d8%a8%d8%b1%d9%88/https://newdrugapprovals.org/wp-content/uploads/2020/01/str1.jpgSTR1https://newdrugapprovals.org/wp-content/uploads/2020/01/str1.gifSTR12023-04-24T09:08:48+00:00monthlyhttps://newdrugapprovals.org/2023/03/09/smartchem-from-row2-technologies/2023-03-09T13:36:32+00:00monthlyhttps://newdrugapprovals.org/2023/01/17/top-10-prominent-great-personalities-of-the-year-2022-campaign-by-fame-finders/https://newdrugapprovals.org/wp-content/uploads/2023/02/img-20230130-wa0029.jpgimg-20230130-wa0029https://newdrugapprovals.org/wp-content/uploads/2023/01/deccan-herald-2.jpgdeccan-herald-2https://newdrugapprovals.org/wp-content/uploads/2023/01/deccan-herald-1.jpgdeccan-herald-1https://newdrugapprovals.org/wp-content/uploads/2023/01/top-10.jpgtop-10https://newdrugapprovals.org/wp-content/uploads/2023/01/1673870807179.jpg16738708071792023-02-02T02:52:49+00:00monthlyhttps://newdrugapprovals.org/2023/01/26/amcenestrant-sar-439859/2023-01-26T03:16:02+00:00monthlyhttps://newdrugapprovals.org/2023/01/22/myself-anthony-crasto-up-for-grabs-as-advisor-api-int-chem/https://newdrugapprovals.org/wp-content/uploads/2023/01/cons-open-a-m-crasto.jpgcons-open-a-m-crasto2023-06-14T05:03:40+00:00monthlyhttps://newdrugapprovals.org/2023/01/14/sc-52458-forasartan/https://newdrugapprovals.org/wp-content/uploads/2023/01/wdt-1.jpgwdt-12023-01-14T03:24:26+00:00monthlyhttps://newdrugapprovals.org/2023/01/04/adagrasib/https://newdrugapprovals.org/wp-content/uploads/2023/01/wdt.jpgwdt2023-01-04T02:52:30+00:00monthlyhttps://newdrugapprovals.org/2022/12/27/nirsevimab/https://newdrugapprovals.org/wp-content/uploads/2022/12/wdt-2.jpgwdt-22022-12-27T02:50:06+00:00monthlyhttps://newdrugapprovals.org/2022/12/20/olutasidenib/https://newdrugapprovals.org/wp-content/uploads/2022/12/wdt-1.jpgwdt-12022-12-20T02:50:17+00:00monthlyhttps://newdrugapprovals.org/2022/12/04/aby-737/https://newdrugapprovals.org/wp-content/uploads/2022/12/wdt.jpgwdt2022-12-04T03:04:53+00:00monthlyhttps://newdrugapprovals.org/2022/11/26/tolebrutinib-sar-442168/https://newdrugapprovals.org/wp-content/uploads/2022/11/image.pngimagehttps://newdrugapprovals.org/wp-content/uploads/2022/11/wdt-3.jpgwdt-32022-11-26T03:30:46+00:00monthlyhttps://newdrugapprovals.org/2022/11/16/mirvetuximab-soravtansine-gynx/https://newdrugapprovals.org/wp-content/uploads/2022/11/wdt-2.jpgwdt-22022-11-16T11:17:35+00:00monthlyhttps://newdrugapprovals.org/2022/11/02/terevalefim/https://newdrugapprovals.org/wp-content/uploads/2022/11/wdt.jpgwdt2022-11-02T02:48:40+00:00monthlyhttps://newdrugapprovals.org/2022/10/27/tremelimumab/https://newdrugapprovals.org/wp-content/uploads/2022/10/wdt-4.jpgwdt-42022-10-27T02:33:40+00:00monthlyhttps://newdrugapprovals.org/2022/10/14/daxibotulinumtoxin-a/https://newdrugapprovals.org/wp-content/uploads/2022/10/wdt-3.jpgwdt-32022-10-14T02:48:42+00:00monthlyhttps://newdrugapprovals.org/2022/10/12/ozoralizumab/https://newdrugapprovals.org/wp-content/uploads/2022/10/wdt-2.jpgwdt-22022-10-12T02:34:07+00:00monthlyhttps://newdrugapprovals.org/2022/10/07/futibatinib/https://newdrugapprovals.org/wp-content/uploads/2022/10/wdt-1.jpgwdt-12022-10-07T08:35:31+00:00monthlyhttps://newdrugapprovals.org/2021/07/13/deucravacitinib/2022-10-04T02:44:58+00:00monthlyhttps://newdrugapprovals.org/2022/10/01/lutetium-177lu-chloride/https://newdrugapprovals.org/wp-content/uploads/2022/10/wdt.jpgwdt2022-10-01T03:11:41+00:00monthlyhttps://newdrugapprovals.org/2022/09/22/terlipressin-acetate/2022-10-01T02:53:07+00:00monthlyhttps://newdrugapprovals.org/2022/09/30/elraglusib/https://newdrugapprovals.org/wp-content/uploads/2022/09/wdt-7.jpgwdt-72022-09-30T02:30:57+00:00monthlyhttps://newdrugapprovals.org/2022/09/29/valemetostat-tosilate/https://newdrugapprovals.org/wp-content/uploads/2022/09/wdt-6.jpgwdt-62022-09-29T02:49:27+00:00monthlyhttps://newdrugapprovals.org/2022/09/28/gadopiclenol/https://newdrugapprovals.org/wp-content/uploads/2022/09/wdt-5.jpgwdt-52022-09-28T02:55:25+00:00monthlyhttps://newdrugapprovals.org/2022/09/24/eflapegrastim/https://newdrugapprovals.org/wp-content/uploads/2022/09/wdt-4.jpgwdt-42022-09-24T13:23:18+00:00monthlyhttps://newdrugapprovals.org/2022/09/21/lorpucitinib/https://newdrugapprovals.org/wp-content/uploads/2022/09/wdt-3.jpgwdt-32022-09-21T03:12:15+00:00monthlyhttps://newdrugapprovals.org/2022/09/09/betibeglogene-autotemcel/https://newdrugapprovals.org/wp-content/uploads/2022/09/wdt-2.jpgwdt-22022-09-09T07:53:21+00:00monthlyhttps://newdrugapprovals.org/2022/09/07/spesolimab/https://newdrugapprovals.org/wp-content/uploads/2022/09/wdt.jpgwdt2022-09-07T03:05:19+00:00monthlyhttps://newdrugapprovals.org/2018/07/14/fda-approves-the-first-drug-tpoxx-tecovirimat-with-an-indication-for-treatment-of-smallpox/https://newdrugapprovals.org/wp-content/uploads/2018/07/r-1.jpgr 12022-09-01T11:30:21+00:00monthlyhttps://newdrugapprovals.org/2022/08/28/icenticaftor/2022-08-28T10:05:37+00:00monthlyhttps://newdrugapprovals.org/2022/08/28/chief-advisor-industry-advisory-board-amity-university-noida-india-26th-aug-2022/https://newdrugapprovals.org/wp-content/uploads/2022/08/300801485_8001905429852118_1249365777804119918_n-1.jpg300801485_8001905429852118_1249365777804119918_n-1https://newdrugapprovals.org/wp-content/uploads/2022/08/300863031_8001906993185295_6449067864242888479_n.jpg300863031_8001906993185295_6449067864242888479_nhttps://newdrugapprovals.org/wp-content/uploads/2022/08/300771728_8001906806518647_6626210397946841282_n.jpg300771728_8001906806518647_6626210397946841282_nhttps://newdrugapprovals.org/wp-content/uploads/2022/08/301113637_8001905619852099_8656443313713577140_n.jpg301113637_8001905619852099_8656443313713577140_nhttps://newdrugapprovals.org/wp-content/uploads/2022/08/300801485_8001905429852118_1249365777804119918_n.jpg300801485_8001905429852118_1249365777804119918_nhttps://newdrugapprovals.org/wp-content/uploads/2022/08/300820957_8001905126518815_7691560619583314873_n.jpg300820957_8001905126518815_7691560619583314873_n2022-08-28T04:46:46+00:00monthlyhttps://newdrugapprovals.org/2022/08/24/camizestrant-azd-9833/https://newdrugapprovals.org/wp-content/uploads/2022/08/wdt-3.jpgwdt-32022-08-24T03:22:04+00:00monthlyhttps://newdrugapprovals.org/2022/08/19/gemcitabine/https://newdrugapprovals.org/wp-content/uploads/2022/08/gem-3.jpggem-3https://newdrugapprovals.org/wp-content/uploads/2022/08/gem-2.jpggem-2https://newdrugapprovals.org/wp-content/uploads/2022/08/gem-1.jpggem-1https://newdrugapprovals.org/wp-content/uploads/2022/08/wdt-2.jpgwdt-22022-08-19T02:31:25+00:00monthlyhttps://newdrugapprovals.org/2022/08/03/oteracil-pottasium/https://newdrugapprovals.org/wp-content/uploads/2022/08/wdt-1.jpgwdt-12022-08-03T02:39:22+00:00monthlyhttps://newdrugapprovals.org/2022/08/02/gimeracil/https://newdrugapprovals.org/wp-content/uploads/2022/08/wdt.jpgwdt2022-08-02T02:51:44+00:00monthlyhttps://newdrugapprovals.org/2022/03/08/triamcinolone/2022-08-02T02:19:03+00:00monthlyhttps://newdrugapprovals.org/2022/07/26/danavorexton-tak-925/https://newdrugapprovals.org/wp-content/uploads/2022/07/wdt-2.jpgwdt-22022-07-26T02:30:46+00:00monthlyhttps://newdrugapprovals.org/2022/07/09/atisoban/https://newdrugapprovals.org/wp-content/uploads/2022/07/str1.jpgstr1https://newdrugapprovals.org/wp-content/uploads/2022/07/wdt-1.jpgwdt-12022-07-09T03:17:35+00:00monthlyhttps://newdrugapprovals.org/2014/04/10/cabotegravir-gsk-744-in-phase-2-for-hiv-infection/https://newdrugapprovals.org/wp-content/uploads/2022/06/str1-14.jpgstr1-14https://newdrugapprovals.org/wp-content/uploads/2022/06/str2-5.jpgstr2-5https://newdrugapprovals.org/wp-content/uploads/2022/06/str1-13.jpgstr1-13https://newdrugapprovals.org/wp-content/uploads/2022/06/str2-4.jpgstr2-4https://newdrugapprovals.org/wp-content/uploads/2022/06/str1-12.jpgstr1-12https://newdrugapprovals.org/wp-content/uploads/2022/06/str1-11.jpgstr1-11https://newdrugapprovals.org/wp-content/uploads/2022/06/str1-10.jpgstr1-10https://newdrugapprovals.org/wp-content/uploads/2022/06/str1-9.jpgstr1-9https://newdrugapprovals.org/wp-content/uploads/2022/06/str1-8.jpgstr1-8https://newdrugapprovals.org/wp-content/uploads/2022/06/str1-7.jpgstr1-72022-06-29T03:06:42+00:00monthlyhttps://newdrugapprovals.org/2022/06/28/darinaparsin/https://newdrugapprovals.org/wp-content/uploads/2022/06/str1-4.jpgstr1-4https://newdrugapprovals.org/wp-content/uploads/2022/06/wdt-5.jpgwdt-52022-06-28T02:53:57+00:00monthlyhttps://newdrugapprovals.org/2022/06/26/pimitespib/https://newdrugapprovals.org/wp-content/uploads/2022/06/wdt-4.jpgwdt-4https://newdrugapprovals.org/wp-content/uploads/2022/06/str1-3.jpgstr1-32022-06-26T03:01:28+00:00monthlyhttps://newdrugapprovals.org/2022/06/20/vp1-001/https://newdrugapprovals.org/wp-content/uploads/2022/06/wdt-3.jpgwdt-3https://newdrugapprovals.org/wp-content/uploads/2022/06/str5-1.jpgstr5-1https://newdrugapprovals.org/wp-content/uploads/2022/06/str4-1.jpgstr4-1https://newdrugapprovals.org/wp-content/uploads/2022/06/str3-1.jpgstr3-1https://newdrugapprovals.org/wp-content/uploads/2022/06/str2-2.jpgstr2-2https://newdrugapprovals.org/wp-content/uploads/2022/06/str1-2.jpgstr1-2https://newdrugapprovals.org/wp-content/uploads/2022/06/str6.jpgstr62023-01-16T22:19:22+00:00monthlyhttps://newdrugapprovals.org/2022/06/17/vutrisiran-sodium-aln-65492-votrisiran/https://newdrugapprovals.org/wp-content/uploads/2022/06/wdt-2.jpgwdt-22022-06-17T03:12:01+00:00monthlyhttps://newdrugapprovals.org/2022/06/13/difluprednate/https://newdrugapprovals.org/wp-content/uploads/2022/06/wdt-1.jpgwdt-1https://newdrugapprovals.org/wp-content/uploads/2022/06/str5.jpgstr5https://newdrugapprovals.org/wp-content/uploads/2022/06/str4.jpgstr4https://newdrugapprovals.org/wp-content/uploads/2022/06/str3.jpgstr3https://newdrugapprovals.org/wp-content/uploads/2022/06/str2-1.jpgstr2-1https://newdrugapprovals.org/wp-content/uploads/2022/06/str1-1.jpgstr1-12022-06-13T13:58:04+00:00monthlyhttps://newdrugapprovals.org/2022/06/08/cobitolimod/https://newdrugapprovals.org/wp-content/uploads/2022/06/wdt.jpgwdt2022-06-08T02:27:13+00:00monthlyhttps://newdrugapprovals.org/2022/06/08/dr-d-srinivasa-reddy-appointed-director-csir-iict-hyderabad-india-on-7th-june-2022-a-new-assignment/https://newdrugapprovals.org/wp-content/uploads/2022/06/str1.jpgstr1https://newdrugapprovals.org/wp-content/uploads/2022/06/str2.jpgstr22022-06-08T09:14:31+00:00monthlyhttps://newdrugapprovals.org/2019/09/13/benvitimod-tapinarof-%d1%82%d0%b0%d0%bf%d0%b8%d0%bd%d0%b0%d1%80%d0%be%d1%84-%d8%aa%d8%a7%d8%a8%d9%8a%d9%86%d8%a7%d8%b1%d9%88%d9%81-%e4%bb%96%e5%8c%b9%e9%82%a3%e7%bd%97/2022-05-31T02:23:38+00:00monthlyhttps://newdrugapprovals.org/2022/05/20/imipridone/https://newdrugapprovals.org/wp-content/uploads/2022/05/wdt-3.jpgwdt-3https://newdrugapprovals.org/wp-content/uploads/2022/05/str4.jpgstr4https://newdrugapprovals.org/wp-content/uploads/2022/05/str3.jpgstr3https://newdrugapprovals.org/wp-content/uploads/2022/05/str2.jpgstr2https://newdrugapprovals.org/wp-content/uploads/2022/05/str1-4.jpgstr1-42022-05-20T08:27:22+00:00monthlyhttps://newdrugapprovals.org/2022/05/18/tirzepatide/https://newdrugapprovals.org/wp-content/uploads/2022/05/eda5c-b20311_685552bd4f974edab109695eaf210cb8mv2.webpb20311_685552bd4f974edab109695eaf210cb8~mv2https://newdrugapprovals.org/wp-content/uploads/2022/05/wdt-2.jpgwdt-2https://newdrugapprovals.org/wp-content/uploads/2022/05/str1-3.jpgstr1-32022-05-18T09:43:04+00:00monthlyhttps://newdrugapprovals.org/2022/05/12/closantel/https://newdrugapprovals.org/wp-content/uploads/2022/05/wdt-1.jpgwdt-12022-05-12T12:02:34+00:00monthlyhttps://newdrugapprovals.org/2022/05/06/monensin/https://newdrugapprovals.org/wp-content/uploads/2022/05/wdt.jpgwdthttps://newdrugapprovals.org/wp-content/uploads/2022/05/m2.jpgm2https://newdrugapprovals.org/wp-content/uploads/2022/05/m1.jpgm12022-05-06T02:32:24+00:00monthlyhttps://newdrugapprovals.org/2022/04/27/sibutramine/2022-04-27T08:41:31+00:00monthlyhttps://newdrugapprovals.org/2021/03/23/novawax-nvx-cov2373/2022-04-26T02:37:40+00:00monthlyhttps://newdrugapprovals.org/2022/04/22/olipudase-alfa/2022-04-22T06:19:49+00:00monthlyhttps://newdrugapprovals.org/2013/12/28/tolvaptan-european-medicines-agency-ema-accepts-otsukas-marketing-authorisation-application-maa-for-tolvaptan/https://newdrugapprovals.org/wp-content/uploads/2013/12/str1-1.jpgstr1https://newdrugapprovals.org/wp-content/uploads/2013/12/to01.pngTO0https://newdrugapprovals.org/wp-content/uploads/2013/12/to0.pngTO0https://newdrugapprovals.org/wp-content/uploads/2013/12/to5.pngto5https://newdrugapprovals.org/wp-content/uploads/2013/12/to4.pngto4https://newdrugapprovals.org/wp-content/uploads/2013/12/to3.pngto3https://newdrugapprovals.org/wp-content/uploads/2013/12/to2.pngto2https://newdrugapprovals.org/wp-content/uploads/2013/12/to1.pngto1https://newdrugapprovals.org/wp-content/uploads/2013/12/t4.pngt4https://newdrugapprovals.org/wp-content/uploads/2013/12/t3.pngt32022-04-21T04:37:03+00:00monthlyhttps://newdrugapprovals.org/2022/04/20/andexanet-alfa/2022-04-20T02:34:42+00:00monthlyhttps://newdrugapprovals.org/2022/04/18/ferric-derisomaltose/2022-04-18T05:54:59+00:00monthlyhttps://newdrugapprovals.org/2022/04/06/toldimfos-sodium/2022-04-06T08:35:16+00:00monthlyhttps://newdrugapprovals.org/2022/04/05/carotegrast-methyl/2022-04-05T05:45:51+00:00monthlyhttps://newdrugapprovals.org/2020/07/09/desidustat/https://newdrugapprovals.org/wp-content/uploads/2020/07/str2-1.jpgstr2https://newdrugapprovals.org/wp-content/uploads/2020/07/str2.jpgstr2https://newdrugapprovals.org/wp-content/uploads/2020/07/str1-1.jpgstr1https://newdrugapprovals.org/wp-content/uploads/2020/07/str1.jpgstr12022-03-30T02:42:21+00:00monthlyhttps://newdrugapprovals.org/2022/03/29/risperidone/2022-03-29T02:22:39+00:00monthlyhttps://newdrugapprovals.org/2022/03/28/lutetium-lu-177-vipivotide-tetraxetan/2022-03-28T08:13:03+00:00monthlyhttps://newdrugapprovals.org/2022/03/27/crenolanib/2022-03-27T09:31:49+00:00monthlyhttps://newdrugapprovals.org/2022/03/19/ciltacabtagene-autoleucel/2022-03-19T08:31:09+00:00monthlyhttps://newdrugapprovals.org/2019/04/06/solriamfetol-hydrochloride-%e3%82%bd%e3%83%ab%e3%83%aa%e3%82%a2%e3%83%a0%e3%83%95%e3%82%a7%e3%83%88%e3%83%ab%e5%a1%a9%e9%85%b8%e5%a1%a9-%d1%81%d0%be%d0%bb%d1%80%d0%b8%d0%b0%d0%bc%d1%84%d0%b5%d1%82/https://newdrugapprovals.org/wp-content/uploads/2019/04/str4.jpgSTR4https://newdrugapprovals.org/wp-content/uploads/2019/04/str3.jpgSTR3https://newdrugapprovals.org/wp-content/uploads/2019/04/str2.jpgstr2https://newdrugapprovals.org/wp-content/uploads/2019/04/str1.jpgstr12022-03-12T12:18:16+00:00monthlyhttps://newdrugapprovals.org/2016/01/17/pacritinib/https://newdrugapprovals.org/wp-content/uploads/2016/01/str122.pngstr1https://newdrugapprovals.org/wp-content/uploads/2016/01/str121.pngstr1https://newdrugapprovals.org/wp-content/uploads/2016/01/str120.pngstr1https://newdrugapprovals.org/wp-content/uploads/2016/01/str127.jpgSTR12022-03-10T02:35:42+00:00monthlyhttps://newdrugapprovals.org/2020/09/18/clascoterone/2022-02-26T02:50:36+00:00monthlyhttps://newdrugapprovals.org/2021/01/03/vildagliptin/2022-02-23T09:13:36+00:00monthlyhttps://newdrugapprovals.org/2022/02/23/radotinib/2022-02-23T04:00:59+00:00monthlyhttps://newdrugapprovals.org/2022/02/18/cyclobenzaprine/2022-02-18T08:54:33+00:00monthlyhttps://newdrugapprovals.org/2022/02/16/pyritinol/2022-02-16T10:22:59+00:00monthlyhttps://newdrugapprovals.org/2021/06/26/dapagliflozin/2022-02-15T08:52:24+00:00monthlyhttps://newdrugapprovals.org/2022/02/12/liranaftate/2022-02-12T06:52:19+00:00monthlyhttps://newdrugapprovals.org/2022/02/11/fabomotizole/2022-02-11T06:05:27+00:00monthlyhttps://newdrugapprovals.org/2022/02/10/sutimlimab-jome/2022-02-10T08:24:29+00:00monthlyhttps://newdrugapprovals.org/2022/02/07/artemether/2022-02-07T08:58:57+00:00monthlyhttps://newdrugapprovals.org/2016/12/05/lumefantrine/https://newdrugapprovals.org/wp-content/uploads/2016/12/str1-1.jpgstr1https://newdrugapprovals.org/wp-content/uploads/2016/12/str11.jpgstr1https://newdrugapprovals.org/wp-content/uploads/2016/12/str04.jpgstr0https://newdrugapprovals.org/wp-content/uploads/2016/12/str1.jpgstr1https://newdrugapprovals.org/wp-content/uploads/2016/12/str03.jpgstr0https://newdrugapprovals.org/wp-content/uploads/2016/12/str02.jpgstr0https://newdrugapprovals.org/wp-content/uploads/2016/12/b3552-str0.jpgb3552-str0https://newdrugapprovals.org/wp-content/uploads/2016/12/str01.jpgstr0https://newdrugapprovals.org/wp-content/uploads/2016/12/str0.jpgstr02022-02-07T02:39:08+00:00monthlyhttps://newdrugapprovals.org/2020/03/21/arbidol-umifenovir/2022-02-06T08:47:33+00:00monthlyhttps://newdrugapprovals.org/2022/02/05/bifonazole/2022-02-05T08:36:47+00:00monthlyhttps://newdrugapprovals.org/2022/02/04/melitracen/2022-02-04T05:40:12+00:00monthlyhttps://newdrugapprovals.org/2022/02/03/iodoquinol/2022-02-03T10:53:46+00:00monthlyhttps://newdrugapprovals.org/2022/02/03/faricimab-svoa/2022-02-03T04:05:43+00:00monthlyhttps://newdrugapprovals.org/2022/02/01/somatrogon/2022-02-01T04:16:20+00:00monthlyhttps://newdrugapprovals.org/2022/01/31/tebentafusp-tebn/2022-01-31T02:39:19+00:00monthlyhttps://newdrugapprovals.org/2022/01/28/vip-152-bay-1251152/2022-01-28T06:47:07+00:00monthlyhttps://newdrugapprovals.org/2021/10/29/ritonavir/2022-01-26T13:16:37+00:00monthlyhttps://newdrugapprovals.org/2022/01/26/fluphenazine/2022-01-26T08:40:41+00:00monthlyhttps://newdrugapprovals.org/2022/01/25/adapalene/2022-01-25T11:27:34+00:00monthlyhttps://newdrugapprovals.org/2019/08/05/pf-04965842-abrocitinib/https://newdrugapprovals.org/wp-content/uploads/2019/08/str1.jpgstr12022-01-25T02:54:43+00:00monthlyhttps://newdrugapprovals.org/2022/01/23/fam-trastuzumab-deruxtecan-nxki/2022-01-23T04:17:50+00:00monthlyhttps://newdrugapprovals.org/2018/01/22/lasmiditan/https://newdrugapprovals.org/wp-content/uploads/2018/01/str1-3.jpgstr1https://newdrugapprovals.org/wp-content/uploads/2018/01/str1-2.jpgstr1https://newdrugapprovals.org/wp-content/uploads/2018/01/str1-1.jpgstr1https://newdrugapprovals.org/wp-content/uploads/2018/01/str1.jpgstr1https://newdrugapprovals.org/wp-content/uploads/2018/01/noname012.pngnoname01https://newdrugapprovals.org/wp-content/uploads/2018/01/noname011.pngnoname01https://newdrugapprovals.org/wp-content/uploads/2018/01/noname01.pngnoname012022-01-22T09:46:59+00:00monthlyhttps://newdrugapprovals.org/2022/01/20/tixagevimab/2022-01-20T10:06:38+00:00monthlyhttps://newdrugapprovals.org/2022/01/18/dipyridamole/2022-01-20T04:52:51+00:00monthlyhttps://newdrugapprovals.org/2022/01/20/daridorexant/2022-01-20T03:18:27+00:00monthlyhttps://newdrugapprovals.org/2022/01/18/anthony-crasto-is-now-consultant-glenmark-lifesciences-at-glenmark-life-sciences/2022-01-18T06:29:15+00:00monthlyhttps://newdrugapprovals.org/2022/01/15/racecadotril/https://newdrugapprovals.org/wp-content/uploads/2022/01/f6588-racecadotril_structural_formulea_violet.jpgRacecadotril_Structural_Formulea_Violet2022-01-15T03:17:59+00:00monthlyhttps://newdrugapprovals.org/2022/01/05/cefadroxil/2022-01-05T04:43:10+00:00monthlyhttps://newdrugapprovals.org/2022/01/05/my-new-drug-approvals-blog-has-clocked-35-lakh-views-in-7-continents-226-countries/2022-01-05T02:45:05+00:00monthlyhttps://newdrugapprovals.org/2022/01/03/cabergoline/2022-01-03T09:33:09+00:00monthlyhttps://newdrugapprovals.org/2016/03/23/brivaracetam/2022-01-02T09:23:59+00:00monthlyhttps://newdrugapprovals.org/2021/12/30/zuclopenthixol/2021-12-30T11:50:10+00:00monthlyhttps://newdrugapprovals.org/2021/12/28/aztreonam/2021-12-28T12:27:34+00:00monthlyhttps://newdrugapprovals.org/2021/04/08/pf-07321332/2021-12-27T06:59:46+00:00monthlyhttps://newdrugapprovals.org/2021/12/23/tezepelumab-ekko/2021-12-23T11:22:03+00:00monthlyhttps://newdrugapprovals.org/2021/12/23/efgartigimod-alfa-fcab/2021-12-23T04:31:01+00:00monthlyhttps://newdrugapprovals.org/2021/01/21/inclisiran/2021-12-23T02:40:38+00:00monthlyhttps://newdrugapprovals.org/2021/12/22/clobetasol/2022-03-29T11:09:34+00:00monthlyhttps://newdrugapprovals.org/2016/02/07/patiromer/https://newdrugapprovals.org/wp-content/uploads/2016/02/8d447-veltassa.jpg8d447-veltassa2021-12-22T04:30:48+00:00monthlyhttps://newdrugapprovals.org/2021/12/22/sevelamer/2021-12-22T04:19:53+00:00monthlyhttps://newdrugapprovals.org/2021/12/11/diroximel-fumarate/2021-12-21T10:40:16+00:00monthlyhttps://newdrugapprovals.org/2021/12/17/rabeximod-rob-803/2021-12-21T10:39:16+00:00monthlyhttps://newdrugapprovals.org/2021/12/21/methocarbamol/2021-12-21T10:36:13+00:00monthlyhttps://newdrugapprovals.org/2021/12/20/citicoline/2021-12-21T05:09:41+00:00monthlyhttps://newdrugapprovals.org/2021/12/20/allopurinol/2021-12-21T05:09:04+00:00monthlyhttps://newdrugapprovals.org/2021/12/20/fomepizole/2021-12-21T05:08:27+00:00monthlyhttps://newdrugapprovals.org/2021/12/21/l-carnosine/2021-12-21T05:06:04+00:00monthlyhttps://newdrugapprovals.org/2021/12/19/povidone-iodine/2021-12-19T02:51:07+00:00monthlyhttps://newdrugapprovals.org/2021/12/18/4-hydroxy-tempo-tempol-mbm-02-mts-01/2021-12-18T04:31:05+00:00monthlyhttps://newdrugapprovals.org/2021/12/16/zy-19489-mmv-253/2021-12-16T11:57:31+00:00monthlyhttps://newdrugapprovals.org/2016/04/27/albutrepenonacog-alfa/2021-12-15T02:06:22+00:00monthlyhttps://newdrugapprovals.org/2021/12/14/pilocarpine/2021-12-14T04:24:41+00:00monthlyhttps://newdrugapprovals.org/2021/12/13/loteprednol-etabonate/2021-12-13T04:17:18+00:00monthlyhttps://newdrugapprovals.org/2021/12/11/regdanvimab/2021-12-11T11:05:35+00:00monthlyhttps://newdrugapprovals.org/2021/12/09/aviptadil/2021-12-09T04:26:06+00:00monthlyhttps://newdrugapprovals.org/2021/12/08/marbofloxacin/2021-12-08T11:27:13+00:00monthlyhttps://newdrugapprovals.org/2021/12/08/staurosporine/2021-12-08T06:24:19+00:00monthlyhttps://newdrugapprovals.org/2021/12/07/alpha-lipoic-acid/2021-12-07T02:09:51+00:00monthlyhttps://newdrugapprovals.org/2021/12/02/maribavir/2021-12-03T02:37:03+00:00monthlyhttps://newdrugapprovals.org/2021/12/02/pafolacianine/2021-12-02T08:46:39+00:00monthlyhttps://newdrugapprovals.org/2021/12/01/amorolfine/2021-12-01T13:18:24+00:00monthlyhttps://newdrugapprovals.org/2021/11/29/acetaminosalol/2021-11-29T09:28:32+00:00monthlyhttps://newdrugapprovals.org/2021/11/26/linzagolix/2021-11-26T05:56:56+00:00monthlyhttps://newdrugapprovals.org/2021/11/25/ropeginterferon-alfa-2b/2021-11-25T02:42:09+00:00monthlyhttps://newdrugapprovals.org/2021/11/23/sulconazole/2021-11-23T04:06:06+00:00monthlyhttps://newdrugapprovals.org/2021/11/16/tno-155/2021-11-16T02:46:58+00:00monthlyhttps://newdrugapprovals.org/2021/11/15/cilengitide/2021-11-15T12:21:14+00:00monthlyhttps://newdrugapprovals.org/2021/11/15/methotripremazine/2021-11-15T04:20:44+00:00monthlyhttps://newdrugapprovals.org/2021/11/13/methiomeprazine/2021-11-13T13:38:19+00:00monthlyhttps://newdrugapprovals.org/2021/11/12/dichlorquinazine/2021-11-12T11:03:02+00:00monthlyhttps://newdrugapprovals.org/2015/12/10/rp-6350-rhizen-pharmaceuticals-s-a-and-novartis-tieup-for-rhizens-inhaled-dual-pl3k-delta-gamma-inhibitor/https://newdrugapprovals.org/wp-content/uploads/2015/12/str11.pngstr1https://newdrugapprovals.org/wp-content/uploads/2015/12/str1.pngstr1https://newdrugapprovals.org/wp-content/uploads/2015/12/str16.jpgstr1https://newdrugapprovals.org/wp-content/uploads/2015/12/str15.jpgstr12021-11-11T04:16:31+00:00monthlyhttps://newdrugapprovals.org/2018/06/25/abl-001-asciminib/2021-11-10T02:39:26+00:00monthlyhttps://newdrugapprovals.org/2021/11/09/leriglitazone/2021-11-09T10:45:00+00:00monthlyhttps://newdrugapprovals.org/2021/11/05/domperidone/2021-11-05T03:36:07+00:00monthlyhttps://newdrugapprovals.org/2021/11/04/mebeverine/2021-11-04T08:32:48+00:00monthlyhttps://newdrugapprovals.org/2021/11/03/sotradecol-sodium-tetradecyl-sulfate/2021-11-03T11:08:11+00:00monthlyhttps://newdrugapprovals.org/2021/11/03/polidocanol/https://newdrugapprovals.org/wp-content/uploads/2021/11/6ebe2-polidocanol.pngPolidocanol2021-11-03T02:41:53+00:00monthlyhttps://newdrugapprovals.org/2021/11/02/docusate/2021-11-02T10:30:41+00:00monthlyhttps://newdrugapprovals.org/2021/11/01/lansoprazole/2021-11-01T10:11:33+00:00monthlyhttps://newdrugapprovals.org/2015/06/15/gefitinib/https://newdrugapprovals.org/wp-content/uploads/2015/06/60661-nmr1.png60661-nmr1https://newdrugapprovals.org/wp-content/uploads/2015/06/839c4-mass1.png839c4-mass12021-11-01T04:32:41+00:00monthlyhttps://newdrugapprovals.org/2021/10/31/prilocaine/2021-10-31T02:53:02+00:00monthlyhttps://newdrugapprovals.org/2021/10/30/cefoperazone/2021-10-30T10:49:01+00:00monthlyhttps://newdrugapprovals.org/2021/10/29/ciclopirox/2021-10-29T10:09:15+00:00monthlyhttps://newdrugapprovals.org/2021/10/28/bupivacaine/2021-10-28T11:14:00+00:00monthlyhttps://newdrugapprovals.org/2021/10/28/ropivacaine/2021-10-28T04:03:16+00:00monthlyhttps://newdrugapprovals.org/2021/10/26/lidocaine/2021-10-26T09:17:18+00:00monthlyhttps://newdrugapprovals.org/2021/10/26/divalproex-sodium/2021-10-26T09:00:38+00:00monthlyhttps://newdrugapprovals.org/2021/10/22/lornoxicam/2021-10-22T06:08:19+00:00monthlyhttps://newdrugapprovals.org/2021/10/21/aupm-170-ca-170-pd-1-in-1/2021-10-22T03:43:57+00:00monthlyhttps://newdrugapprovals.org/2021/10/21/faropenem/2021-10-21T08:47:11+00:00monthlyhttps://newdrugapprovals.org/2016/04/11/curis-and-aurigenes-aupm-170-ca-170/2021-10-21T02:24:40+00:00monthlyhttps://newdrugapprovals.org/2021/10/20/aur-101/https://newdrugapprovals.org/wp-content/uploads/2021/10/92e3c-img_3542.jpgIMG_3542.jpg?format=300w2021-10-20T08:46:19+00:00monthlyhttps://newdrugapprovals.org/2021/10/16/xl-114-aur-104/https://newdrugapprovals.org/wp-content/uploads/2021/10/str1-4.jpgstr1https://newdrugapprovals.org/wp-content/uploads/2021/10/str1-3.jpgstr1https://newdrugapprovals.org/wp-content/uploads/2021/10/str1-2.jpgstr1https://newdrugapprovals.org/wp-content/uploads/2021/10/str1-1.jpgstr12021-10-20T06:02:35+00:00monthlyhttps://newdrugapprovals.org/2021/10/18/jnj-a07/2021-10-18T10:51:31+00:00monthlyhttps://newdrugapprovals.org/2021/10/15/piroxicam/2021-10-15T11:44:29+00:00monthlyhttps://newdrugapprovals.org/2021/10/14/piracetam/2021-10-14T08:16:23+00:00monthlyhttps://newdrugapprovals.org/2021/10/12/meropenem/2021-10-12T04:23:40+00:00monthlyhttps://newdrugapprovals.org/2021/10/09/rtss-as01-rtss-mosquirix/2021-10-10T06:08:05+00:00monthlyhttps://newdrugapprovals.org/2021/10/03/jb1-802-by-jubilant/2021-10-05T08:34:59+00:00monthlyhttps://newdrugapprovals.org/2021/10/05/reach-registration-evaluation-authorisation-and-restriction-of-chemicals/2021-10-05T05:25:03+00:00monthlyhttps://newdrugapprovals.org/2021/10/04/tisotumab-vedotin/2021-10-04T09:31:33+00:00monthlyhttps://newdrugapprovals.org/2020/03/28/eidd-2801/https://newdrugapprovals.org/wp-content/uploads/2020/03/str1-1.jpgstr12021-10-04T04:06:02+00:00monthlyhttps://newdrugapprovals.org/2018/08/02/iobenguane-i-131/2021-10-03T11:56:31+00:00monthlyhttps://newdrugapprovals.org/2018/06/25/atogepant-%d0%b0%d1%82%d0%be%d0%b3%d0%b5%d0%bf%d0%b0%d0%bd%d1%82-%d8%a3%d8%aa%d9%88%d8%ac%d9%8a%d8%a8%d8%a7%d9%86%d8%aa-%e9%98%bf%e6%89%98%e5%90%89%e6%b3%ae/2021-10-03T09:15:20+00:00monthlyhttps://newdrugapprovals.org/2016/06/15/maralixibat-chloride-%d9%85%d8%a7%d8%b1%d8%a7%d9%84%d9%8a%d9%83%d8%b3%d9%8a%d8%a8%d8%a7%d8%aa-%d9%83%d9%84%d9%88%d8%b1%d9%8a%d8%af-%e6%b0%af%e9%a9%ac%e6%98%94%e5%b7%b4%e7%89%b9-%d0%bc%d0%b0/2021-10-03T09:11:28+00:00monthlyhttps://newdrugapprovals.org/2021/09/29/avacopan/2021-09-29T06:39:15+00:00monthlyhttps://newdrugapprovals.org/2021/09/27/biapenem/2021-09-29T02:28:46+00:00monthlyhttps://newdrugapprovals.org/2021/09/24/vx-759/2021-09-24T12:08:16+00:00monthlyhttps://newdrugapprovals.org/2021/09/23/mobocertinib/2021-09-24T12:03:57+00:00monthlyhttps://newdrugapprovals.org/2021/09/22/verdiperstat/2021-09-22T06:35:52+00:00monthlyhttps://newdrugapprovals.org/2021/09/21/vosoritide/2021-09-22T02:30:23+00:00monthlyhttps://newdrugapprovals.org/2021/09/20/mevociclib-sy-1365/2021-09-20T02:37:54+00:00monthlyhttps://newdrugapprovals.org/2021/09/13/sept2021-this-blog-new-drug-approvals-approaching-34-lakh-views/2021-09-19T03:06:01+00:00monthlyhttps://newdrugapprovals.org/2021/09/14/max-40279/2021-09-19T03:04:47+00:00monthlyhttps://newdrugapprovals.org/2021/09/15/afoxolaner/2021-09-19T03:03:09+00:00monthlyhttps://newdrugapprovals.org/2021/09/15/pegvaliase/2021-09-19T03:02:40+00:00monthlyhttps://newdrugapprovals.org/2021/09/16/ferric-pyrophosphate-citrate/2021-09-19T03:02:15+00:00monthlyhttps://newdrugapprovals.org/2021/09/13/saquinavir/2022-03-14T10:53:10+00:00monthlyhttps://newdrugapprovals.org/2021/09/18/sy-5609/2021-09-19T02:56:45+00:00monthlyhttps://newdrugapprovals.org/2021/06/30/23943/2021-09-16T02:36:29+00:00monthlyhttps://newdrugapprovals.org/2015/03/19/dabrafenib-mesylate-gsk-2118436/https://newdrugapprovals.org/wp-content/uploads/2015/03/dabrafenib-route1.jpgDABRAFENIB ROUTEhttps://newdrugapprovals.org/wp-content/uploads/2015/03/dabrafenib-route.jpgDABRAFENIB ROUTEhttps://newdrugapprovals.org/wp-content/uploads/2015/03/screenshot-2.pngscreenshot-2https://newdrugapprovals.org/wp-content/uploads/2015/03/screenshot-www-nmrdb-org-2015-03-20-09-23-51.pngscreenshot-www nmrdb org 2015-03-20 09-23-51https://newdrugapprovals.org/wp-content/uploads/2015/03/image.pngimage2021-09-14T05:50:19+00:00monthlyhttps://newdrugapprovals.org/2014/06/17/the-us-food-and-drug-administration-fda-has-approved-bayer-healthcares-gadavist-gadobutrol-injection-as-the-first-magnetic-resonance-contrast-agent-for-evaluation-of-breast-cancer-in-the-us/2021-09-09T05:57:43+00:00monthlyhttps://newdrugapprovals.org/2021/09/09/benzonatate/2021-09-09T02:45:54+00:00monthlyhttps://newdrugapprovals.org/2021/09/08/plasminogen/2021-09-08T11:24:38+00:00monthlyhttps://newdrugapprovals.org/2021/09/07/abx-464/2021-09-07T13:26:00+00:00monthlyhttps://newdrugapprovals.org/2021/02/18/umbralisib/2021-09-07T02:27:37+00:00monthlyhttps://newdrugapprovals.org/2021/09/06/thiamine-vitamin-b1/2021-09-24T08:47:38+00:00monthlyhttps://newdrugapprovals.org/2021/09/06/tegoprazan/2021-09-06T11:03:51+00:00monthlyhttps://newdrugapprovals.org/2021/09/02/fluvatinib/2021-09-02T02:55:18+00:00monthlyhttps://newdrugapprovals.org/2021/09/01/bimekizumab/2021-09-01T02:42:45+00:00monthlyhttps://newdrugapprovals.org/2021/08/31/difelikefalin-acetate/2021-08-31T02:54:02+00:00monthlyhttps://newdrugapprovals.org/2021/08/29/lonapegsomatropin/2021-08-29T02:39:26+00:00monthlyhttps://newdrugapprovals.org/2021/08/24/mvc-covid-19-vaccine-taiwans-covid-vaccine/2021-08-24T02:40:44+00:00monthlyhttps://newdrugapprovals.org/2021/08/23/pepinemab-vx-15/2021-08-23T09:10:32+00:00monthlyhttps://newdrugapprovals.org/2014/01/10/midazolam/2021-08-23T04:18:08+00:00monthlyhttps://newdrugapprovals.org/2021/08/22/avasopasem-manganese/2021-08-22T09:25:38+00:00monthlyhttps://newdrugapprovals.org/2021/05/14/zycov-d/https://newdrugapprovals.org/wp-content/uploads/2021/05/str1.jpgstr12021-08-21T05:24:18+00:00monthlyhttps://newdrugapprovals.org/2021/08/19/belzutifan/2021-08-19T02:46:10+00:00monthlyhttps://newdrugapprovals.org/2021/08/18/naftopidil-kt-611/2021-08-18T06:21:34+00:00monthlyhttps://newdrugapprovals.org/2021/08/17/pralnacasan/2021-08-17T09:45:01+00:00monthlyhttps://newdrugapprovals.org/2021/08/17/vx-148/2021-08-17T02:22:14+00:00monthlyhttps://newdrugapprovals.org/2021/08/16/vx-3-2-4-fluorophenyl-lh-indol-3-yl-n-3s4r-4-hydroxy-2-oxo-pyrrolidin-3-yl-propanamide/2021-08-16T11:15:22+00:00monthlyhttps://newdrugapprovals.org/2021/08/15/propofol/2021-08-15T09:17:49+00:00monthlyhttps://newdrugapprovals.org/2021/08/15/iohexol/2021-08-15T04:59:45+00:00monthlyhttps://newdrugapprovals.org/2018/06/12/gadobenate-dimeglumine/2021-08-14T09:18:52+00:00monthlyhttps://newdrugapprovals.org/2021/08/14/avalglucosidase-alfa/2021-08-14T02:50:48+00:00monthlyhttps://newdrugapprovals.org/2021/08/12/ono-2910/2021-08-12T02:09:40+00:00monthlyhttps://newdrugapprovals.org/2021/08/11/bemiparin/2021-08-11T10:50:13+00:00monthlyhttps://newdrugapprovals.org/2021/08/10/trk-700/2021-08-10T09:40:00+00:00monthlyhttps://newdrugapprovals.org/2021/08/09/rutoside-rutin/2021-08-09T02:09:45+00:00monthlyhttps://newdrugapprovals.org/2021/08/02/ezutromid/2021-08-08T04:43:49+00:00monthlyhttps://newdrugapprovals.org/2021/08/08/anifrolumab/2021-08-08T04:42:59+00:00monthlyhttps://newdrugapprovals.org/2020/09/14/odevixibat/2021-08-01T02:14:46+00:00monthlyhttps://newdrugapprovals.org/2020/12/14/setmelanotide/2021-08-01T02:10:55+00:00monthlyhttps://newdrugapprovals.org/2021/07/23/melarsoprol/2021-07-29T09:18:25+00:00monthlyhttps://newdrugapprovals.org/2021/07/28/nangibotide/2021-07-28T09:18:39+00:00monthlyhttps://newdrugapprovals.org/2014/06/04/fexinidazole/2021-07-20T10:31:53+00:00monthlyhttps://newdrugapprovals.org/2021/07/11/belumosudil/2021-12-20T10:13:44+00:00monthlyhttps://newdrugapprovals.org/2021/07/18/prn-473-sar-444727/2021-07-18T11:43:57+00:00monthlyhttps://newdrugapprovals.org/2016/10/26/cetilistat-%e3%82%bb%e3%83%81%e3%83%aa%e3%82%b9%e3%82%bf%e3%83%83%e3%83%88/https://newdrugapprovals.org/wp-content/uploads/2016/10/aa312-nmr-cetilistat.pngaa312-nmr-cetilistathttps://newdrugapprovals.org/wp-content/uploads/2016/10/9a5c1-cetilistat.png9a5c1-cetilistathttps://newdrugapprovals.org/wp-content/uploads/2016/10/1b666-cetilistat-syn1.png1b666-cetilistat-syn1https://newdrugapprovals.org/wp-content/uploads/2016/10/9d4ee-str1.jpg9d4ee-str12021-07-18T02:53:38+00:00monthlyhttps://newdrugapprovals.org/2017/03/27/trientine-hydrochloride-%e5%a1%a9%e9%85%b8%e3%83%88%e3%83%aa%e3%82%a8%e3%83%b3%e3%83%81%e3%83%b3-%e6%9b%b2%e6%81%a9%e6%b1%80/2021-07-18T02:52:45+00:00monthlyhttps://newdrugapprovals.org/2016/02/09/finerenone/https://newdrugapprovals.org/wp-content/uploads/2016/02/str111.pngstr1https://newdrugapprovals.org/wp-content/uploads/2016/02/str110.pngstr1https://newdrugapprovals.org/wp-content/uploads/2016/02/str19.pngstr1https://newdrugapprovals.org/wp-content/uploads/2016/02/str18.pngstr12021-07-10T02:22:18+00:00monthlyhttps://newdrugapprovals.org/2021/07/06/asparaginase-erwinia-chrysanthemi-recombinant-rywn/2021-07-06T10:57:26+00:00monthlyhttps://newdrugapprovals.org/2021/07/04/soberana-02-finlay-fr-2/2021-07-04T09:26:01+00:00monthlyhttps://newdrugapprovals.org/2021/07/02/tralokinumab/2021-07-02T02:28:41+00:00monthlyhttps://newdrugapprovals.org/2021/07/01/upacicalcet-sodium-hydrate/2021-07-01T05:04:15+00:00monthlyhttps://newdrugapprovals.org/2021/06/30/cvncov-zorecimeran-curevac-covid-19-vaccine/2021-06-30T08:13:55+00:00monthlyhttps://newdrugapprovals.org/2021/06/29/tucidinostat-chidamide/2021-06-29T06:49:07+00:00monthlyhttps://newdrugapprovals.org/2021/06/29/isotretinoin/2021-06-29T02:40:32+00:00monthlyhttps://newdrugapprovals.org/2021/06/16/nanatinostat/2021-06-28T12:17:46+00:00monthlyhttps://newdrugapprovals.org/2021/06/28/uprifosbuvir/2021-06-28T12:16:19+00:00monthlyhttps://newdrugapprovals.org/2021/06/28/covax-19/2021-06-28T12:12:52+00:00monthlyhttps://newdrugapprovals.org/2021/06/26/arct-021-lunar-cov19/2021-06-26T09:13:08+00:00monthlyhttps://newdrugapprovals.org/2021/06/24/iibr-100/2021-06-24T02:52:11+00:00monthlyhttps://newdrugapprovals.org/2021/06/22/abdala-cigb-66/2021-06-22T05:44:01+00:00monthlyhttps://newdrugapprovals.org/2021/06/22/23865/2021-06-22T04:08:45+00:00monthlyhttps://newdrugapprovals.org/2021/06/21/coviran-barakat/2021-06-21T09:47:51+00:00monthlyhttps://newdrugapprovals.org/2021/06/21/convidicea-ad5-ncov/2021-06-21T03:03:51+00:00monthlyhttps://newdrugapprovals.org/2021/06/20/zf2001-zifivax/2021-06-20T06:23:15+00:00monthlyhttps://newdrugapprovals.org/2021/06/20/epivaccorona/2021-06-20T06:17:40+00:00monthlyhttps://newdrugapprovals.org/2021/06/18/23826/2021-06-20T02:57:34+00:00monthlyhttps://newdrugapprovals.org/2021/06/16/drospirenone/2022-07-30T04:33:11+00:00monthlyhttps://newdrugapprovals.org/2021/06/15/samidorphan/2021-06-15T11:11:41+00:00monthlyhttps://newdrugapprovals.org/2021/06/13/colchicine/2021-06-14T06:16:58+00:00monthlyhttps://newdrugapprovals.org/2021/06/11/piflufolastat-f-18-injection-dcfpyl-f-18/2021-06-11T01:41:24+00:00monthlyhttps://newdrugapprovals.org/2021/06/10/amivantamab/2021-06-10T02:53:32+00:00monthlyhttps://newdrugapprovals.org/2018/06/20/remimazolam/2021-06-10T02:39:27+00:00monthlyhttps://newdrugapprovals.org/2021/06/09/pegcetacoplan/2021-06-09T08:57:13+00:00monthlyhttps://newdrugapprovals.org/2021/06/09/sotorasib/2021-06-09T04:40:50+00:00monthlyhttps://newdrugapprovals.org/2021/06/07/tropifexor/2021-06-07T10:58:28+00:00monthlyhttps://newdrugapprovals.org/2021/06/07/infigratinib-phosphate/2023-10-09T07:03:39+00:00monthlyhttps://newdrugapprovals.org/2021/06/06/corbevax-bioe-covid-19-becov2d/2021-06-06T09:55:21+00:00monthlyhttps://newdrugapprovals.org/2021/06/04/ptx-covid19-b/2021-06-04T13:17:54+00:00monthlyhttps://newdrugapprovals.org/2021/06/01/imdevimab/2022-10-08T14:06:04+00:00monthlyhttps://newdrugapprovals.org/2021/05/31/casirivimab/2021-05-31T03:23:00+00:00monthlyhttps://newdrugapprovals.org/2021/05/08/2-deoxy-d-glucose/2021-05-20T12:35:51+00:00monthlyhttps://newdrugapprovals.org/2021/05/19/idecabtagene-vicleucel/2021-05-19T12:13:21+00:00monthlyhttps://newdrugapprovals.org/2021/05/18/loncastuximab-tesirine/2022-12-23T07:45:29+00:00monthlyhttps://newdrugapprovals.org/2021/05/12/dostarlimab/2021-05-12T03:42:49+00:00monthlyhttps://newdrugapprovals.org/2014/12/02/ramatroban/2021-05-02T10:32:51+00:00monthlyhttps://newdrugapprovals.org/2020/03/12/remdesivir-%e3%83%ac%e3%83%a0%e3%83%87%e3%82%b7%e3%83%93%e3%83%ab-%d1%80%d0%b5%d0%bc%d0%b4%d0%b5%d1%81%d0%b8%d0%b2%d0%b8%d1%80-%d8%b1%d9%8a%d9%85%d8%af%d9%8a%d8%b3%d9%8a%d9%81%d9%8a%d8%b1/2021-04-27T03:23:26+00:00monthlyhttps://newdrugapprovals.org/2020/03/21/favipiravir-%e3%83%95%e3%82%a1%e3%83%93%e3%83%94%e3%83%a9%e3%83%93%e3%83%ab/2021-04-27T03:19:31+00:00monthlyhttps://newdrugapprovals.org/2015/03/04/favipiravir/2021-04-27T03:17:22+00:00monthlyhttps://newdrugapprovals.org/2021/04/24/pegylated-interferon-alpha-2b-pegifn-virafin/2021-05-10T08:16:16+00:00monthlyhttps://newdrugapprovals.org/2021/04/12/dexmethylphenidate/2021-05-10T08:17:36+00:00monthlyhttps://newdrugapprovals.org/2021/04/09/sacituzumab-govitecan-hziy/2021-04-09T12:02:44+00:00monthlyhttps://newdrugapprovals.org/2019/02/27/viloxazine-%e3%83%b4%e3%82%a3%e3%83%ad%e3%82%ad%e3%82%b5%e3%82%b8%e3%83%b3/2021-04-07T04:36:00+00:00monthlyhttps://newdrugapprovals.org/2021/04/03/dasiglucagon/2021-04-07T04:32:27+00:00monthlyhttps://newdrugapprovals.org/2021/03/29/erythromycin/2021-04-07T04:31:57+00:00monthlyhttps://newdrugapprovals.org/2021/03/28/dirithromycin/2021-04-07T04:31:23+00:00monthlyhttps://newdrugapprovals.org/2021/03/26/sinovac-covid-19-vaccine-coronavac/2021-04-07T04:30:57+00:00monthlyhttps://newdrugapprovals.org/2021/03/24/sputnik-v-gam-covid-vac-gamaleya/2021-04-07T04:30:26+00:00monthlyhttps://newdrugapprovals.org/2021/03/24/johnson-johnson-covid-19-vaccine-jnj-78436735/2021-04-07T04:29:48+00:00monthlyhttps://newdrugapprovals.org/2021/04/05/pabinafusp-alfa/2021-04-05T02:44:32+00:00monthlyhttps://newdrugapprovals.org/2021/04/04/diclofenac-etalhyaluronate-sodium/2021-04-04T10:54:52+00:00monthlyhttps://newdrugapprovals.org/2021/04/01/clarithromycin/2021-04-04T10:43:08+00:00monthlyhttps://newdrugapprovals.org/2016/05/28/fda-approves-new-diagnostic-imaging-agent-fluciclovine-f-18-to-detect-recurrent-prostate-cancer/2021-04-04T02:40:17+00:00monthlyhttps://newdrugapprovals.org/2016/06/09/ponesimod/https://newdrugapprovals.org/wp-content/uploads/2016/06/str11.jpgstr1https://newdrugapprovals.org/wp-content/uploads/2016/06/str1.jpgstr12021-04-04T02:35:57+00:00monthlyhttps://newdrugapprovals.org/2018/02/13/abaloparatide-%d0%b0%d0%b1%d0%b0%d0%bb%d0%be%d0%bf%d0%b0%d1%80%d0%b0%d1%82%d0%b8%d0%b4-%d8%a3%d8%a8%d8%a7%d9%84%d9%88%d8%a8%d8%a7%d8%b1%d8%a7%d8%aa%d9%8a%d8%af-%e5%b7%b4%e7%bd%97%e6%97%81/2021-04-03T02:25:03+00:00monthlyhttps://newdrugapprovals.org/2021/03/27/brivudine/2021-03-27T08:57:25+00:00monthlyhttps://newdrugapprovals.org/2021/03/23/bbibp-corv-sinopharm-covid-19-vaccine/2021-03-23T02:54:35+00:00monthlyhttps://newdrugapprovals.org/2021/03/22/sitravatinib/2021-03-22T12:17:34+00:00monthlyhttps://newdrugapprovals.org/2021/03/21/moderna-covid-19-vaccine-mrna-1273/2021-11-29T15:07:05+00:00monthlyhttps://newdrugapprovals.org/2021/03/21/anamorelin-hydrochloride/2021-03-21T13:31:35+00:00monthlyhttps://newdrugapprovals.org/2021/03/10/azd1222-chadox1-oxford-astrazeneca-covid-19-vaccine-covishield/2021-03-21T04:36:23+00:00monthlyhttps://newdrugapprovals.org/2021/02/24/tozinameran-pfizer-biontech-covid%e2%80%9119-vaccine/2021-03-21T04:32:52+00:00monthlyhttps://newdrugapprovals.org/2021/03/17/covaxin-bbv-152/2021-03-21T04:30:36+00:00monthlyhttps://newdrugapprovals.org/2021/03/19/dasatinib/2021-03-19T11:08:11+00:00monthlyhttps://newdrugapprovals.org/2021/03/18/norepinephrine-bitartrate/2021-03-18T08:35:23+00:00monthlyhttps://newdrugapprovals.org/2021/03/16/lenalidomide-hydrate/2021-03-16T05:22:03+00:00monthlyhttps://newdrugapprovals.org/2018/01/09/trilaciclib-g1t28/2021-03-16T02:25:41+00:00monthlyhttps://newdrugapprovals.org/2021/03/15/lisocabtagene-maraleucel/2021-03-15T10:12:58+00:00monthlyhttps://newdrugapprovals.org/2021/03/14/casimersen/2021-03-14T06:45:09+00:00monthlyhttps://newdrugapprovals.org/2021/03/12/fosdenopterin-hydrobromide/2021-03-12T06:32:51+00:00monthlyhttps://newdrugapprovals.org/2021/03/11/melphalan-flufenamide-hydrochloride/2021-03-11T02:38:25+00:00monthlyhttps://newdrugapprovals.org/2021/03/04/everolimus/2021-03-10T02:31:22+00:00monthlyhttps://newdrugapprovals.org/2021/03/08/pyridostigmine/2021-03-08T05:29:53+00:00monthlyhttps://newdrugapprovals.org/2021/03/07/buspirone/2021-03-07T11:30:28+00:00monthlyhttps://newdrugapprovals.org/2021/03/06/azelnidipine/2021-03-06T02:59:05+00:00monthlyhttps://newdrugapprovals.org/2021/03/02/detomidine/2021-03-02T11:36:58+00:00monthlyhttps://newdrugapprovals.org/2021/02/28/fluvoxamine/2021-02-28T10:36:09+00:00monthlyhttps://newdrugapprovals.org/2021/02/26/evinacumab/2021-02-26T09:41:55+00:00monthlyhttps://newdrugapprovals.org/2021/02/21/fenfluramine-hydrochloride/2021-02-21T10:12:05+00:00monthlyhttps://newdrugapprovals.org/2015/12/11/tgr-1202-a-phosphoinositide-3-kinase-delta-inhibitor-rhizen-pharmaceuticals-s-a-tg-therapeutics/https://newdrugapprovals.org/wp-content/uploads/2015/12/str18.jpgstr1https://newdrugapprovals.org/wp-content/uploads/2015/12/str17.jpgstr12021-02-18T09:13:09+00:00monthlyhttps://newdrugapprovals.org/2014/09/16/10708/2021-02-17T02:29:08+00:00monthlyhttps://newdrugapprovals.org/2021/02/15/imrecoxib/2021-02-15T09:54:14+00:00monthlyhttps://newdrugapprovals.org/2021/02/11/telacebec/2021-02-14T12:54:27+00:00monthlyhttps://newdrugapprovals.org/2021/02/09/iguratimod/2021-02-10T02:21:48+00:00monthlyhttps://newdrugapprovals.org/2014/07/04/fda-grants-orphan-designation-to-galdermas-skin-disease-drug-trifarotene/2021-02-01T11:03:05+00:00monthlyhttps://newdrugapprovals.org/2021/01/27/ridinilazole/2023-06-30T10:24:55+00:00monthlyhttps://newdrugapprovals.org/2021/01/25/oi-338/2021-01-25T10:16:17+00:00monthlyhttps://newdrugapprovals.org/2021/01/25/devimistat/2021-01-25T10:10:45+00:00monthlyhttps://newdrugapprovals.org/2021/01/24/fosnetupitant/2021-01-24T09:18:21+00:00monthlyhttps://newdrugapprovals.org/2021/01/23/centhaquine/2021-01-23T13:12:03+00:00monthlyhttps://newdrugapprovals.org/2019/09/04/pretomanid-%e3%83%97%e3%83%ac%e3%83%88%e3%83%9e%e3%83%8b%e3%83%89/2021-01-23T12:57:50+00:00monthlyhttps://newdrugapprovals.org/2014/07/22/cti-biopharma-receives-israeli-approval-for-aggressive-b-cell-non-hodgkins-lymphoma-therapy/2021-01-23T12:54:08+00:00monthlyhttps://newdrugapprovals.org/2020/04/30/voclosporin/https://newdrugapprovals.org/wp-content/uploads/2020/04/str1-1.jpgstr1https://newdrugapprovals.org/wp-content/uploads/2020/04/str1.jpgstr12021-06-06T04:04:27+00:00monthlyhttps://newdrugapprovals.org/2021/01/23/esketamine/2021-01-23T02:29:22+00:00monthlyhttps://newdrugapprovals.org/2021/01/15/ciglitazone/2021-01-15T04:29:04+00:00monthlyhttps://newdrugapprovals.org/2015/04/27/tazemetostat/https://newdrugapprovals.org/wp-content/uploads/2015/04/taz-13.pngTAZ 13https://newdrugapprovals.org/wp-content/uploads/2015/04/taz-13-2.pngTAZ 13 2https://newdrugapprovals.org/wp-content/uploads/2015/04/taz-1h-nmr.pngTAZ 1H NMR2021-01-14T10:55:49+00:00monthlyhttps://newdrugapprovals.org/2021/01/14/bms-262084/2021-01-14T10:52:46+00:00monthlyhttps://newdrugapprovals.org/2013/04/10/chinas-sfda-ready-to-fast-track-approvals-of-peramivir-a-flu-treatment/2021-01-13T03:07:57+00:00monthlyhttps://newdrugapprovals.org/2021/01/11/idebenone/2021-02-10T09:48:05+00:00monthlyhttps://newdrugapprovals.org/2021/01/10/pf-3635659/2021-01-27T11:18:45+00:00monthlyhttps://newdrugapprovals.org/2021/01/09/bindarit/2021-01-09T06:01:17+00:00monthlyhttps://newdrugapprovals.org/2021/01/07/roluperidone/2021-01-08T01:47:52+00:00monthlyhttps://newdrugapprovals.org/2021/01/06/glucagon/2021-01-06T02:32:35+00:00monthlyhttps://newdrugapprovals.org/2021/01/05/vonicog-alfa/2021-01-05T02:24:37+00:00monthlyhttps://newdrugapprovals.org/2021/01/04/dofetilide/2021-01-04T11:32:39+00:00monthlyhttps://newdrugapprovals.org/2020/12/29/catequentinib-anlotinib/2020-12-29T13:06:38+00:00monthlyhttps://newdrugapprovals.org/2020/12/27/lurbinectedin/2020-12-28T02:20:22+00:00monthlyhttps://newdrugapprovals.org/2020/12/26/naxitamab/2020-12-26T02:48:31+00:00monthlyhttps://newdrugapprovals.org/2020/12/25/ansuvimab-zykl/2020-12-25T04:18:04+00:00monthlyhttps://newdrugapprovals.org/2019/01/21/relugolix-%e3%83%ac%e3%83%ab%e3%82%b4%e3%83%aa%e3%82%af%e3%82%b9/https://newdrugapprovals.org/wp-content/uploads/2019/01/24994-1546627904836.png24994-15466279048362020-12-25T04:02:20+00:00monthlyhttps://newdrugapprovals.org/2014/10/06/vibegron-mk-4618-for-for-the-treatment-of-overactive-bladder/https://newdrugapprovals.org/wp-content/uploads/2014/10/cc038-str1.pngcc038-str1https://newdrugapprovals.org/wp-content/uploads/2014/10/acfe3-str1.pngacfe3-str1https://newdrugapprovals.org/wp-content/uploads/2014/10/f22fa-str1.pngf22fa-str12020-12-25T03:58:39+00:00monthlyhttps://newdrugapprovals.org/2016/04/21/plecanatide-%e6%99%ae%e5%8d%a1%e9%82%a3%e8%82%bd-%d9%84%d9%8a%d9%83%d8%a7%d9%86%d8%a7%d8%aa%d9%8a%d8%af-%d0%bf%d0%bb%d0%b5%d0%ba%d0%b0%d0%bd%d0%b0%d1%82%d0%b8%d0%b4/2020-12-23T10:06:57+00:00monthlyhttps://newdrugapprovals.org/2020/12/20/citrulline/2020-12-20T13:16:11+00:00monthlyhttps://newdrugapprovals.org/2020/12/19/etrumadenant/2020-12-19T02:18:40+00:00monthlyhttps://newdrugapprovals.org/2015/08/18/filgotinib/https://newdrugapprovals.org/wp-content/uploads/2015/08/13c-nmr-molbase-val.png13C NMR MOLBASE VALhttps://newdrugapprovals.org/wp-content/uploads/2015/08/13c-nmr-molbase-graph.png13C NMR MOLBASE GRAPHhttps://newdrugapprovals.org/wp-content/uploads/2015/08/1h-nmr-molbase-val.png1H NMR MOLBASE VALhttps://newdrugapprovals.org/wp-content/uploads/2015/08/1h-nmr-molbase-graph.png1H NMR MOLBASE GRAPHhttps://newdrugapprovals.org/wp-content/uploads/2015/08/nmr-medkoo.pngNMR MEDKOOhttps://newdrugapprovals.org/wp-content/uploads/2015/08/nmr-abmole.pngNMR ABMOLE2020-12-18T01:54:30+00:00monthlyhttps://newdrugapprovals.org/2020/12/17/amikacin-sulfate/https://newdrugapprovals.org/wp-content/uploads/2020/12/94672-amikacin.jpgamikacin2020-12-17T02:42:53+00:00monthlyhttps://newdrugapprovals.org/2020/12/16/tirbanibulin/2020-12-16T13:08:17+00:00monthlyhttps://newdrugapprovals.org/2020/12/15/lonafarnib/2020-12-15T10:45:34+00:00monthlyhttps://newdrugapprovals.org/2020/12/15/gallium-68-psma-11/2020-12-15T04:32:48+00:00monthlyhttps://newdrugapprovals.org/2020/12/15/lumasiran/2020-12-15T02:04:22+00:00monthlyhttps://newdrugapprovals.org/2020/12/14/melatonin/2020-12-14T03:38:28+00:00monthlyhttps://newdrugapprovals.org/2018/01/25/delafloxacin/2020-12-13T10:43:54+00:00monthlyhttps://newdrugapprovals.org/2020/12/13/isatuximab/2020-12-13T05:10:20+00:00monthlyhttps://newdrugapprovals.org/2020/12/13/borofalan-10b/2020-12-13T02:20:44+00:00monthlyhttps://newdrugapprovals.org/2020/12/12/tepotinib-hydrochloride/2020-12-12T02:10:28+00:00monthlyhttps://newdrugapprovals.org/2020/12/11/tirabrutinib/2020-12-11T02:22:33+00:00monthlyhttps://newdrugapprovals.org/2020/12/10/berotralstat/2020-12-10T03:54:58+00:00monthlyhttps://newdrugapprovals.org/2020/12/09/viltolarsen/2021-09-18T16:09:58+00:00monthlyhttps://newdrugapprovals.org/2020/12/08/pemigatinib/2020-12-08T15:34:28+00:00monthlyhttps://newdrugapprovals.org/2020/12/04/raloxifene/2020-12-04T02:16:34+00:00monthlyhttps://newdrugapprovals.org/2020/11/23/tucatinib/2020-11-23T08:36:48+00:00monthlyhttps://newdrugapprovals.org/2020/11/16/ripretinib/2020-11-16T12:19:57+00:00monthlyhttps://newdrugapprovals.org/2020/11/13/reproxalap/https://newdrugapprovals.org/wp-content/uploads/2020/11/str1.jpg.pngstr1.JPG2020-11-14T02:41:46+00:00monthlyhttps://newdrugapprovals.org/2020/11/01/lercanidipine/2020-11-01T02:19:31+00:00monthlyhttps://newdrugapprovals.org/2020/11/01/spinosad/2020-11-01T02:17:17+00:00monthlyhttps://newdrugapprovals.org/2020/10/26/triheptanoin/2020-10-26T02:28:49+00:00monthlyhttps://newdrugapprovals.org/2020/10/24/milvexian/2020-10-24T11:02:31+00:00monthlyhttps://newdrugapprovals.org/2020/10/12/cetuximab-sarotalocan-sodium/2020-10-12T02:20:33+00:00monthlyhttps://newdrugapprovals.org/2016/10/30/design-and-synthesis-of-indoline-thiohydantoin-derivatives-based-on-enzalutamide-as-antiproliferative-agents-against-prostate-cancer/https://newdrugapprovals.org/wp-content/uploads/2016/10/03620-str0.jpg03620-str02020-10-10T08:52:26+00:00monthlyhttps://newdrugapprovals.org/2020/10/07/enarodustat/2020-10-07T02:29:17+00:00monthlyhttps://newdrugapprovals.org/2020/10/01/sofpironium-bromide/2020-12-03T12:29:04+00:00monthlyhttps://newdrugapprovals.org/2020/09/29/tetrahydrobiopterin/2020-09-29T08:53:36+00:00monthlyhttps://newdrugapprovals.org/2020/09/26/bulevirtide-acetate/2020-09-26T02:24:21+00:00monthlyhttps://newdrugapprovals.org/nmpa-china/https://newdrugapprovals.org/wp-content/uploads/2020/09/str1.jpgstr12020-09-25T04:39:50+00:00weekly0.6https://newdrugapprovals.org/korea-drug-approval-process/2020-09-24T11:28:44+00:00weekly0.6https://newdrugapprovals.org/2020/09/23/nifurtimox/2020-09-23T02:35:43+00:00monthlyhttps://newdrugapprovals.org/2020/09/22/imlifidase/2020-09-22T02:27:50+00:00monthlyhttps://newdrugapprovals.org/2020/09/20/pralsetinib/2020-09-20T05:17:41+00:00monthlyhttps://newdrugapprovals.org/2020/09/15/somapacitan-%e3%82%bd%e3%83%9e%e3%83%91%e3%82%b7%e3%82%bf%e3%83%b3/2020-09-16T05:39:05+00:00monthlyhttps://newdrugapprovals.org/2020/09/13/copper-cu-64-dotatate-%e9%8a%85cu64%e3%83%89%e3%83%bc%e3%82%bf%e3%83%86%e3%83%bc%e3%83%88/2020-09-13T03:54:10+00:00monthlyhttps://newdrugapprovals.org/2013/06/17/lilly-and-partner-incyte-corp-have-presented-more-promising-data-on-their-investigational-jak-inhibitor-baricitinib-for-rheumatoid-arthritis/https://newdrugapprovals.org/wp-content/uploads/2013/06/str3-1.jpgstr3https://newdrugapprovals.org/wp-content/uploads/2013/06/str2-1.jpgstr2https://newdrugapprovals.org/wp-content/uploads/2013/06/str1-1.jpgstr1https://newdrugapprovals.org/wp-content/uploads/2013/06/str4.jpgstr4https://newdrugapprovals.org/wp-content/uploads/2013/06/str3.jpgstr3https://newdrugapprovals.org/wp-content/uploads/2013/06/str21.jpgstr2https://newdrugapprovals.org/wp-content/uploads/2013/06/str12.jpgstr1https://newdrugapprovals.org/wp-content/uploads/2013/06/str11.jpgstr1https://newdrugapprovals.org/wp-content/uploads/2013/06/str2.jpgstr2https://newdrugapprovals.org/wp-content/uploads/2013/06/str1.jpgstr12020-09-09T13:02:10+00:00monthlyhttps://newdrugapprovals.org/2020/03/29/azithromycin/https://newdrugapprovals.org/wp-content/uploads/2020/03/str1-2.jpgstr1https://newdrugapprovals.org/wp-content/uploads/2020/03/str2-1.jpgstr22020-09-09T08:35:58+00:00monthlyhttps://newdrugapprovals.org/2014/02/02/zanamivir-relenza-for-the-prevention-and-treatment-of-influenza-a-and-b/2020-09-07T09:42:44+00:00monthlyhttps://newdrugapprovals.org/2020/09/05/cilofexor-2/2020-09-05T09:11:54+00:00monthlyhttps://newdrugapprovals.org/2020/09/03/lazuvapagon/2020-09-03T02:33:36+00:00monthlyhttps://newdrugapprovals.org/2020/08/27/molindone-%d0%bc%d0%be%d0%bb%d0%b8%d0%bd%d0%b4%d0%be%d0%bd-%d9%85%d9%88%d9%84%d9%8a%d9%86%d8%af%d9%88%d9%86-%e5%90%97%e8%8c%9a%e9%85%ae/2020-08-27T03:08:16+00:00monthlyhttps://newdrugapprovals.org/2020/08/19/tildacerfont/2020-08-19T04:28:46+00:00monthlyhttps://newdrugapprovals.org/2020/08/13/sulcardine-sulphate/2020-08-13T05:02:09+00:00monthlyhttps://newdrugapprovals.org/2020/07/30/diquafosol/2020-07-30T03:28:49+00:00monthlyhttps://newdrugapprovals.org/2020/07/27/bay-1895344/https://newdrugapprovals.org/wp-content/uploads/2020/07/bay.jpgbay2020-07-28T10:59:51+00:00monthlyhttps://newdrugapprovals.org/2020/07/26/mk-5204/2020-07-26T13:39:26+00:00monthlyhttps://newdrugapprovals.org/2020/07/25/selgantolimod/2020-07-25T09:07:12+00:00monthlyhttps://newdrugapprovals.org/2020/06/04/gst-hg-121/2020-06-04T12:55:18+00:00monthlyhttps://newdrugapprovals.org/2020/05/26/naronapride/https://newdrugapprovals.org/wp-content/uploads/2020/05/str1-2.jpgstr1https://newdrugapprovals.org/wp-content/uploads/2020/05/str1-1.jpgstr1https://newdrugapprovals.org/wp-content/uploads/2020/05/str2.jpgstr2https://newdrugapprovals.org/wp-content/uploads/2020/05/str1.jpgstr12020-06-04T05:40:08+00:00monthlyhttps://newdrugapprovals.org/2020/03/25/chloroquine/2020-04-17T22:48:26+00:00monthlyhttps://newdrugapprovals.org/2020/03/24/niclosamide-%e3%83%8b%e3%82%af%e3%83%ad%e3%82%b5%e3%83%9f%e3%83%89-%d0%bd%d0%b8%d0%ba%d0%bb%d0%be%d1%81%d0%b0%d0%bc%d0%b8%d0%b4-%d9%86%d9%8a%d9%83%d9%84%d9%88%d8%b3%d8%a7%d9%85%d9%8a%d8%af/2020-03-24T04:02:48+00:00monthlyhttps://newdrugapprovals.org/2020/03/22/nitazoxanide-%e3%83%8b%e3%82%bf%e3%82%be%e3%82%ad%e3%82%b5%e3%83%8b%e3%83%89/2020-03-24T03:45:08+00:00monthlyhttps://newdrugapprovals.org/2020/03/22/galidesivir/2020-09-05T18:38:45+00:00monthlyhttps://newdrugapprovals.org/2020/03/21/hydroxychloroquine-%e3%83%92%e3%83%89%e3%83%ad%e3%82%ad%e3%82%b7%e3%82%af%e3%83%ad%e3%83%ad%e3%82%ad%e3%83%b3/https://newdrugapprovals.org/wp-content/uploads/2020/03/str2.jpgstr2https://newdrugapprovals.org/wp-content/uploads/2020/03/str1.jpgstr12020-10-08T10:03:00+00:00monthlyhttps://newdrugapprovals.org/2020/03/16/camostat-mesilate-%e3%82%ab%e3%83%a2%e3%82%b9%e3%82%bf%e3%83%83%e3%83%88%e3%83%a1%e3%82%b7%e3%83%ab%e9%85%b8%e5%a1%a9%e3%80%80%e6%97%a5%e5%b1%80%e5%8f%8e%e8%bc%89/2020-03-16T09:30:30+00:00monthlyhttps://newdrugapprovals.org/2020/03/12/lanraprenib/2020-03-12T09:10:46+00:00monthlyhttps://newdrugapprovals.org/2020/03/12/lactitol-%e3%83%a9%e3%82%af%e3%83%81%e3%83%88%e3%83%bc%e3%83%ab/2020-03-12T08:54:07+00:00monthlyhttps://newdrugapprovals.org/2020/03/11/abbv-744/2020-03-11T11:32:16+00:00monthlyhttps://newdrugapprovals.org/2020/03/11/nidufexor/2020-03-11T11:24:15+00:00monthlyhttps://newdrugapprovals.org/2020/03/11/lnp-023/2020-03-11T11:20:12+00:00monthlyhttps://newdrugapprovals.org/2020/03/11/eptinezumab-%e3%82%a8%e3%83%97%e3%83%81%e3%83%8d%e3%82%ba%e3%83%9e%e3%83%96/2020-03-11T11:14:59+00:00monthlyhttps://newdrugapprovals.org/2020/03/04/amisulpride-%e3%82%a2%e3%83%9f%e3%82%b9%e3%83%ab%e3%83%97%e3%83%aa%e3%83%89/2020-03-04T13:31:12+00:00monthlyhttps://newdrugapprovals.org/2020/03/03/rimegepant-sulfate-%e3%83%aa%e3%83%a1%e3%82%b2%e3%83%91%e3%83%b3%e3%83%88%e7%a1%ab%e9%85%b8%e5%a1%a9/2020-03-04T01:03:10+00:00monthlyhttps://newdrugapprovals.org/2020/02/28/tranilast/2020-02-28T14:19:50+00:00monthlyhttps://newdrugapprovals.org/2020/02/24/lys-228/2020-02-24T10:24:47+00:00monthlyhttps://newdrugapprovals.org/2020/02/19/adx-103/2020-02-19T09:16:55+00:00monthlyhttps://newdrugapprovals.org/2020/02/13/islatravir-mk-8591-efda/2020-02-13T09:48:34+00:00monthlyhttps://newdrugapprovals.org/2020/02/12/lns-8801-srr-g-1/2020-02-12T10:52:52+00:00monthlyhttps://newdrugapprovals.org/2020/02/11/cc-90010/2020-02-11T08:52:28+00:00monthlyhttps://newdrugapprovals.org/2016/06/22/roxadustat-asp-1517-fg-4592/https://newdrugapprovals.org/wp-content/uploads/2016/06/str1-1.jpgstr12020-02-05T11:03:10+00:00monthlyhttps://newdrugapprovals.org/2020/02/05/dotinurad-%e3%83%89%e3%83%81%e3%83%8c%e3%83%a9%e3%83%89/2020-02-05T10:48:51+00:00monthlyhttps://newdrugapprovals.org/2020/01/29/iiim-290/2023-02-10T13:21:32+00:00monthlyhttps://newdrugapprovals.org/2020/01/25/teprotumumab-trbw/2020-07-01T23:08:18+00:00monthlyhttps://newdrugapprovals.org/2020/01/24/encorafenib-%e3%82%a8%e3%83%b3%e3%82%b3%e3%83%a9%e3%83%95%e3%82%a7%e3%83%8b%e3%83%96/2020-01-24T10:36:23+00:00monthlyhttps://newdrugapprovals.org/2020/01/21/grapiprant/2020-01-21T10:59:32+00:00monthlyhttps://newdrugapprovals.org/2020/01/20/brilliant-blue-g-%e3%83%96%e3%83%aa%e3%83%aa%e3%82%a2%e3%83%b3%e3%83%88%e3%83%96%e3%83%ab%e3%83%bcg/2020-01-20T13:31:34+00:00monthlyhttps://newdrugapprovals.org/2020/01/17/fluorodopa-f-18-%e3%83%95%e3%83%ab%e3%82%aa%e3%83%ad%e3%83%89%e3%83%91-18f-%d1%84%d0%bb%d1%83%d0%be%d1%80%d0%be%d0%b4%d0%be%d0%bf%d0%b0-18f-%d9%81%d9%84%d9%88%d8%b1%d9%88%d8%af%d9%88%d8%a8/2020-01-17T10:16:41+00:00monthlyhttps://newdrugapprovals.org/2020/01/14/enfortumab-vedotin/2020-01-14T10:27:25+00:00monthlyhttps://newdrugapprovals.org/2020/01/13/avapritinib-%e3%82%a2%e3%83%90%e3%83%97%e3%83%aa%e3%83%81%e3%83%8b%e3%83%96-%d0%b0%d0%b2%d0%b0%d0%bf%d1%80%d0%b8%d1%82%d0%b8%d0%bd%d0%b8%d0%b1-%d8%a3%d9%81%d8%a7%d8%a8%d8%b1%d9%8a%d8%aa%d9%8a/2020-01-13T09:38:02+00:00monthlyhttps://newdrugapprovals.org/2020/01/08/teriparatide-%e3%83%86%e3%83%aa%e3%83%91%e3%83%a9%e3%83%81%e3%83%89-%d1%82%d0%b5%d1%80%d0%b8%d0%bf%d0%b0%d1%80%d0%b0%d1%82%d0%b8%d0%b4-%d8%aa%d9%8a%d8%b1%d9%8a%d8%a8%d8%a7%d8%b1%d8%a7%d8%aa%d9%8a/2020-01-08T09:31:49+00:00monthlyhttps://newdrugapprovals.org/2020/01/07/coblopasvir/2020-01-07T08:38:42+00:00monthlyhttps://newdrugapprovals.org/2019/12/27/adafosbuvir-%d0%b0%d0%b4%d0%b0%d1%84%d0%be%d1%81%d0%b1%d1%83%d0%b2%d0%b8%d1%80-%d8%a3%d8%af%d8%a7%d9%81%d9%88%d8%b3%d8%a8%d9%88%d9%81%d9%8a%d8%b1/2019-12-27T09:11:53+00:00monthlyhttps://newdrugapprovals.org/2019/12/26/cefiderocol-%e3%82%bb%e3%83%95%e3%82%a3%e3%83%87%e3%83%ad%e3%82%b3%e3%83%ab-%d1%86%d0%b5%d1%84%d0%b8%d0%b4%d0%b5%d1%80%d0%be%d0%ba%d0%be%d0%bb-%d8%b3%d9%8a%d9%81%d9%8a%d8%af%d9%8a%d8%b1%d9%88/2019-12-26T09:55:08+00:00monthlyhttps://newdrugapprovals.org/2019/12/23/givosiran-%e3%82%ae%e3%83%9c%e3%82%b7%e3%83%a9%e3%83%b3/2019-12-23T10:28:16+00:00monthlyhttps://newdrugapprovals.org/2019/12/20/golodirsen-%e3%82%b4%e3%83%ad%e3%82%b8%e3%83%ab%e3%82%bb%e3%83%b3/2019-12-20T08:51:24+00:00monthlyhttps://newdrugapprovals.org/2019/11/26/fda-approves-novel-treatment-oxbryta-voxelotor-to-target-abnormality-in-sickle-cell-disease/2019-11-26T11:00:37+00:00monthlyhttps://newdrugapprovals.org/2019/11/22/fda-approves-new-treatment-xcopri-cenobamate-tablets-for-adults-with-partial-onset-seizures/2019-11-22T13:26:40+00:00monthlyhttps://newdrugapprovals.org/2019/11/21/fda-approves-first-treatment-givlaari-givosiran-for-inherited-rare-disease/2019-11-21T10:47:46+00:00monthlyhttps://newdrugapprovals.org/2019/11/01/blarcamesine-%e3%83%96%e3%83%a9%e3%83%ab%e3%82%ab%e3%83%a1%e3%82%b7%e3%83%b3/2019-11-01T09:24:35+00:00monthlyhttps://newdrugapprovals.org/2019/10/25/leuprorelin-%e3%83%aa%e3%83%a5%e3%83%bc%e3%83%97%e3%83%ad%e3%83%ac%e3%83%aa%e3%83%b3/2019-10-25T13:26:06+00:00monthlyhttps://newdrugapprovals.org/2019/10/16/penfluridol/2019-10-16T09:35:28+00:00monthlyhttps://newdrugapprovals.org/2019/10/13/elacridar/2019-10-13T10:49:12+00:00monthlyhttps://newdrugapprovals.org/2019/10/10/azeliragon/2019-10-10T13:36:44+00:00monthlyhttps://newdrugapprovals.org/2019/10/09/afamelanotide-%e3%82%a2%e3%83%95%e3%82%a1%e3%83%a1%e3%83%a9%e3%83%8e%e3%83%81%e3%83%89-%d0%b0%d1%84%d0%b0%d0%bc%d0%b5%d0%bb%d0%b0%d0%bd%d0%be%d1%82%d0%b8%d0%b4-%d8%a3%d9%81%d8%a7%d9%85%d9%8a/2019-10-09T09:39:36+00:00monthlyhttps://newdrugapprovals.org/2019/10/03/valacyclovir-hcl/2019-10-03T13:55:00+00:00monthlyhttps://newdrugapprovals.org/2019/10/03/flecainide-acetate/2019-10-03T13:53:24+00:00monthlyhttps://newdrugapprovals.org/2019/10/03/desvenlafaxine-succinate/2021-12-12T01:35:34+00:00monthlyhttps://newdrugapprovals.org/2019/10/03/methyl-dopa/2019-10-03T10:20:15+00:00monthlyhttps://newdrugapprovals.org/2019/10/01/vidofludimus/2019-10-01T09:43:10+00:00monthlyhttps://newdrugapprovals.org/2019/10/01/edotreotide-gallium-ga-68/2019-10-01T09:40:53+00:00monthlyhttps://newdrugapprovals.org/2019/09/27/lenalidomide-%e3%83%ac%e3%83%8a%e3%83%aa%e3%83%89%e3%83%9f%e3%83%89-%d0%bb%d0%b5%d0%bd%d0%b0%d0%bb%d0%b8%d0%b4%d0%be%d0%bc%d0%b8%d0%b4-%d9%84%d9%8a%d9%86%d8%a7%d9%84%d9%8a%d8%af%d9%88%d9%85%d9%8a/2019-09-28T09:22:39+00:00monthlyhttps://newdrugapprovals.org/2019/09/27/nilotinib-%e3%83%8b%e3%83%ad%e3%83%81%e3%83%8b%e3%83%96/2019-09-27T09:38:58+00:00monthlyhttps://newdrugapprovals.org/2019/09/12/canertinib/2019-09-12T03:27:55+00:00monthlyhttps://newdrugapprovals.org/2019/09/10/cilastatin-%d1%86%d0%b8%d0%bb%d0%b0%d1%81%d1%82%d0%b0%d1%82%d0%b8%d0%bd-%d8%b3%d9%8a%d9%84%d8%a7%d8%b3%d8%aa%d8%a7%d8%aa%d9%8a%d9%86-%e8%a5%bf%e5%8f%b8%e4%bb%96%e4%b8%81/2019-09-10T10:46:46+00:00monthlyhttps://newdrugapprovals.org/2019/09/06/j-147/2019-09-06T06:51:48+00:00monthlyhttps://newdrugapprovals.org/2019/09/05/dicycloplatin/2019-09-05T10:10:28+00:00monthlyhttps://newdrugapprovals.org/2019/08/31/fda-approves-first-treatment-dupixent-dupilumab-for-chronic-rhinosinusitis-with-nasal-polyps/2019-08-31T02:50:36+00:00monthlyhttps://newdrugapprovals.org/2019/08/30/octamoxin-%d0%be%d0%ba%d1%82%d0%b0%d0%bc%d0%be%d0%ba%d1%81%d0%b8%d0%bd-%d8%a3%d9%88%d9%83%d8%aa%d8%a7%d9%85%d9%88%d9%83%d8%b3%d9%8a%d9%86-%e5%a5%a5%e4%bb%96%e8%8e%ab%e8%be%9b/2019-08-30T14:34:40+00:00monthlyhttps://newdrugapprovals.org/2019/08/30/ck-101/2019-08-30T14:30:55+00:00monthlyhttps://newdrugapprovals.org/2019/08/30/labetalol-hydrochloride-%e3%83%a9%e3%83%99%e3%82%bf%e3%83%ad%e3%83%bc%e3%83%ab/2019-08-30T14:27:47+00:00monthlyhttps://newdrugapprovals.org/2019/08/28/fda-approves-new-add-on-drug-nourianz-istradefylline-to-treat-off-episodes-in-adults-with-parkinsons-disease/2019-08-28T09:43:25+00:00monthlyhttps://newdrugapprovals.org/2019/08/20/fda-approves-treatment-inrebic-fedratinib-for-patients-with-rare-bone-marrow-disorder/2019-08-20T10:36:34+00:00monthlyhttps://newdrugapprovals.org/2016/08/26/pitolisant/2019-08-20T10:35:38+00:00monthlyhttps://newdrugapprovals.org/2018/08/31/ferric-maltol-%e3%83%9e%e3%83%ab%e3%83%88%e3%83%bc%e3%83%ab%e7%ac%ac%e4%ba%8c%e9%89%84/2019-08-20T10:31:42+00:00monthlyhttps://newdrugapprovals.org/2019/08/20/fda-approves-third-oncology-drug-rozlytrek-entrectinib-that-targets-a-key-genetic-driver-of-cancer-rather-than-a-specific-type-of-tumor/2019-08-20T10:25:14+00:00monthlyhttps://newdrugapprovals.org/2019/08/20/fda-approves-new-antibiotic-xenleta-lefamulin-to-treat-community-acquired-bacterial-pneumonia/2019-08-20T10:22:04+00:00monthlyhttps://newdrugapprovals.org/2019/08/16/ak-3280/2019-08-16T10:15:43+00:00monthlyhttps://newdrugapprovals.org/2019/08/14/novobiocin-%e3%83%8e%e3%83%9c%e3%83%93%e3%82%aa%e3%82%b7%e3%83%b3/2019-08-14T09:22:26+00:00monthlyhttps://newdrugapprovals.org/2019/08/08/imipenem-%e3%82%a4%e3%83%9f%e3%83%9a%e3%83%8d%e3%83%a0%e6%b0%b4%e5%92%8c%e7%89%a9/2019-11-13T07:41:44+00:00monthlyhttps://newdrugapprovals.org/2019/08/07/sk1-i-bml-258/2019-08-07T13:30:37+00:00monthlyhttps://newdrugapprovals.org/2018/05/26/pf-04965842/2019-08-05T11:56:21+00:00monthlyhttps://newdrugapprovals.org/2019/07/31/syn-01/2019-07-31T09:34:45+00:00monthlyhttps://newdrugapprovals.org/2019/07/31/lk-01-apomorphine/2019-07-31T09:33:26+00:00monthlyhttps://newdrugapprovals.org/2019/07/29/sy-008/2019-07-29T10:09:18+00:00monthlyhttps://newdrugapprovals.org/2019/07/29/fasoracetam/2019-07-29T10:05:31+00:00monthlyhttps://newdrugapprovals.org/2019/07/26/bq-788/2019-07-26T10:04:55+00:00monthlyhttps://newdrugapprovals.org/2019/07/25/fluazolepali-%e6%b0%9f%e5%94%91%e5%b8%95%e5%88%a9-fluzoparib/2019-07-25T13:31:05+00:00monthlyhttps://newdrugapprovals.org/2019/07/23/wxfl-10203614/2019-07-23T12:56:51+00:00monthlyhttps://newdrugapprovals.org/2019/07/22/tanzisertib/2019-07-23T05:13:10+00:00monthlyhttps://newdrugapprovals.org/2019/07/22/cc-90009/2019-07-22T13:27:44+00:00monthlyhttps://newdrugapprovals.org/2019/07/22/quinacillin/2019-07-22T13:24:04+00:00monthlyhttps://newdrugapprovals.org/2019/07/16/selinexor/2019-07-16T09:07:50+00:00monthlyhttps://newdrugapprovals.org/2019/07/11/reldesemtiv/2019-07-11T10:14:00+00:00monthlyhttps://newdrugapprovals.org/2019/07/11/picropodophyllin/2019-07-11T10:08:13+00:00monthlyhttps://newdrugapprovals.org/2019/07/09/selpercatinib/2019-07-09T09:56:58+00:00monthlyhttps://newdrugapprovals.org/2019/07/05/unoprostone/2019-07-05T11:01:01+00:00monthlyhttps://newdrugapprovals.org/2019/07/05/hec-68498/2022-05-19T12:29:40+00:00monthlyhttps://newdrugapprovals.org/2019/07/04/gne-0877/2019-07-04T09:24:04+00:00monthlyhttps://newdrugapprovals.org/2019/07/04/nicotinamide-riboside-chloride/2019-07-04T09:20:20+00:00monthlyhttps://newdrugapprovals.org/2019/07/04/new-patent-opicapone-wo-2019123066-unichem/2019-07-04T09:16:41+00:00monthlyhttps://newdrugapprovals.org/2019/07/03/quinupramine-%e3%82%ad%e3%83%8c%e3%83%97%e3%83%a9%e3%83%9f%e3%83%b3/2019-07-03T10:39:41+00:00monthlyhttps://newdrugapprovals.org/2019/07/02/hs-10340/2019-07-02T13:26:45+00:00monthlyhttps://newdrugapprovals.org/2019/06/28/fda-approves-first-treatment-soliris-eculizumab-for-neuromyelitis-optica-spectrum-disorder-a-rare-autoimmune-disease-of-the-central-nervous-system/2019-06-28T10:46:13+00:00monthlyhttps://newdrugapprovals.org/2019/06/28/cs-3001/2019-06-28T10:41:09+00:00monthlyhttps://newdrugapprovals.org/2019/06/28/tl-487/2019-06-28T10:38:41+00:00monthlyhttps://newdrugapprovals.org/2019/06/28/tenapanor/2019-06-28T09:52:31+00:00monthlyhttps://newdrugapprovals.org/2019/06/27/hm04-or-h0900/2019-06-27T08:46:44+00:00monthlyhttps://newdrugapprovals.org/2019/06/26/gfh-018/2019-06-26T10:05:23+00:00monthlyhttps://newdrugapprovals.org/2019/06/25/fda-approves-new-treatment-vyleesi-bremelanotide-for-hypoactive-sexual-desire-disorder-in-premenopausal-women/2019-06-25T12:50:33+00:00monthlyhttps://newdrugapprovals.org/2015/02/18/palatins-bremelanotide-under-clinical-trials-female-libido-enhancer/2019-06-25T12:47:54+00:00monthlyhttps://newdrugapprovals.org/2019/06/21/piclidenoson-%d0%b8%d0%ba%d0%bb%d0%b8%d0%b4%d0%b5%d0%bd%d0%be%d0%b7%d0%be%d0%bd-%d8%a8%d9%8a%d9%83%d9%84%d9%8a%d8%af%d9%8a%d9%86%d9%88%d8%b3%d9%88%d9%86-%e5%8c%b9%e5%88%a9%e8%af%ba%e7%94%9f/2019-06-21T09:59:24+00:00monthlyhttps://newdrugapprovals.org/2019/06/20/shr-0532/2019-06-20T10:13:10+00:00monthlyhttps://newdrugapprovals.org/2019/06/19/seviteronel-%d1%81%d0%b5%d0%b2%d0%b8%d1%82%d0%b5%d1%80%d0%be%d0%bd%d0%b5%d0%bb-%d8%b3%d9%8a%d9%81%d9%8a%d8%aa%d9%8a%d8%b1%d9%88%d9%86%d9%8a%d9%84-%e8%b5%9b%e7%bb%b4%e7%bd%97%e5%a5%88/2019-06-19T13:08:58+00:00monthlyhttps://newdrugapprovals.org/2019/06/18/fda-approves-new-treatment-victoza-liraglutide-for-pediatric-patients-with-type-2-diabetes/2019-06-18T10:35:36+00:00monthlyhttps://newdrugapprovals.org/2019/06/18/vx-445-elexacaftor-%e3%82%a8%e3%83%ac%e3%82%af%e3%82%b5%e3%82%ab%e3%83%95%e3%83%88%e3%83%ab/2019-06-18T10:30:51+00:00monthlyhttps://newdrugapprovals.org/2019/06/04/abacavir-2/2019-06-04T10:54:51+00:00monthlyhttps://newdrugapprovals.org/2019/06/04/fda-approves-new-treatment-for-hospital-acquired-and-ventilator-associated-bacterial-pneumonia/2019-06-04T10:49:16+00:00monthlyhttps://newdrugapprovals.org/2019/05/31/onasemnogene-abeparvovec-%e3%82%aa%e3%83%8a%e3%82%bb%e3%83%a0%e3%83%8e%e3%82%b8%e3%83%bc%e3%83%b3%e3%82%a2%e3%83%99%e3%83%91%e3%83%ab%e3%83%9c%e3%83%99%e3%83%83%e3%82%af/2019-05-31T09:51:22+00:00monthlyhttps://newdrugapprovals.org/2019/05/29/fda-approves-first-pi3k-inhibitor-piqray-alpelisib-for-breast-cancer/2019-05-29T10:47:43+00:00monthlyhttps://newdrugapprovals.org/2019/05/18/ct-1812/2019-05-18T03:38:11+00:00monthlyhttps://newdrugapprovals.org/2019/05/15/dipivefrine-%d0%b4%d0%b8%d0%bf%d0%b8%d0%b2%d0%b5%d1%84%d1%80%d0%b8%d0%bd-%d8%af%d9%8a%d8%a8%d9%8a%d9%81%d9%8a%d9%81%d8%b1%d9%8a%d9%86-%e5%9c%b0%e5%8c%b9%e7%a6%8f%e6%9e%97-%e3%82%b8%e3%83%94/2019-05-15T09:39:19+00:00monthlyhttps://newdrugapprovals.org/2019/05/15/etosalamide-%d1%8d%d1%82%d0%be%d1%81%d0%b0%d0%bb%d0%b0%d0%bc%d0%b8%d0%b4-%d8%a5%d9%8a%d8%aa%d9%88%d8%b3%d8%a7%d9%84%d8%a7%d9%85%d9%8a%d8%af-%e4%be%9d%e6%89%98%e6%9f%b3%e8%83%ba/2019-05-15T09:36:05+00:00monthlyhttps://newdrugapprovals.org/2019/05/10/fda-approves-first-treatment-ruzurgi-amifampridine-for-children-with-lambert-eaton-myasthenic-syndrome-a-rare-autoimmune-disorder/2019-05-10T10:07:43+00:00monthlyhttps://newdrugapprovals.org/2019/05/10/beperminogene-perplasmid-%e3%83%99%e3%83%9a%e3%83%ab%e3%83%9f%e3%83%8e%e3%82%b2%e3%83%b3%e3%83%9a%e3%83%ab%e3%83%97%e3%83%a9%e3%82%b9%e3%83%9f%e3%83%89/2019-05-10T10:03:54+00:00monthlyhttps://newdrugapprovals.org/2019/05/10/bi-882370/2019-05-10T09:58:25+00:00monthlyhttps://newdrugapprovals.org/2019/05/07/aclimostat/2019-05-07T09:59:46+00:00monthlyhttps://newdrugapprovals.org/2019/05/06/srt-1720/2019-05-06T10:57:40+00:00monthlyhttps://newdrugapprovals.org/2019/05/04/ketorolac/2019-05-04T13:50:45+00:00monthlyhttps://newdrugapprovals.org/2019/05/04/cavosonstat-n-91115/2019-05-04T10:03:12+00:00monthlyhttps://newdrugapprovals.org/2019/05/03/deutivacaftor/2019-05-03T10:00:30+00:00monthlyhttps://newdrugapprovals.org/2019/05/02/vx-659-bamocaftor-potassium/2019-05-02T10:16:36+00:00monthlyhttps://newdrugapprovals.org/2019/05/02/first-fda-approved-vaccine-dengvaxia-for-the-prevention-of-dengue-disease-in-endemic-regions/2019-11-27T16:58:31+00:00monthlyhttps://newdrugapprovals.org/2019/05/02/erdafitinib-%e3%82%a8%e3%83%ab%e3%83%80%e3%83%95%e3%82%a3%e3%83%81%e3%83%8b%e3%83%96-%d1%8d%d1%80%d0%b4%d0%b0%d1%84%d0%b8%d1%82%d0%b8%d0%bd%d0%b8%d0%b1-%d8%a5%d9%8a%d8%b1%d8%af%d8%a7%d9%81%d9%8a/2021-02-02T17:38:12+00:00monthlyhttps://newdrugapprovals.org/2019/04/27/fda-approves-first-treatment-for-pediatric-patients-with-lupus/2019-04-27T03:32:59+00:00monthlyhttps://newdrugapprovals.org/2019/04/22/ferric-carboxymaltose-%e3%82%ab%e3%83%ab%e3%83%9c%e3%82%ad%e3%82%b7%e3%83%9e%e3%83%ab%e3%83%88%e3%83%bc%e3%82%b9%e7%ac%ac%e4%ba%8c%e9%89%84/2019-04-22T13:05:42+00:00monthlyhttps://newdrugapprovals.org/2019/04/18/thiotepa-%e3%83%81%e3%82%aa%e3%83%86%e3%83%91-%d1%82%d0%b8%d0%be%d1%82%d0%b5%d0%bf%d0%b0-%d8%ab%d9%8a%d9%88%d8%aa%d9%8a%d8%a8%d8%a7-%e5%a1%9e%e6%9b%bf%e6%b4%be/2019-04-18T10:27:36+00:00monthlyhttps://newdrugapprovals.org/2019/04/17/vixotrigine-new-patent-wo-2019071162-biogen-inc/2019-04-17T09:27:05+00:00monthlyhttps://newdrugapprovals.org/2019/04/17/peficitinib-hydrobromide-%e3%83%9a%e3%83%95%e3%82%a3%e3%82%b7%e3%83%81%e3%83%8b%e3%83%96%e8%87%ad%e5%8c%96%e6%b0%b4%e7%b4%a0%e9%85%b8%e5%a1%a9/2019-04-17T09:25:09+00:00monthlyhttps://newdrugapprovals.org/2019/04/17/cefamandole-%e3%82%bb%e3%83%95%e3%82%a1%e3%83%9e%e3%83%b3%e3%83%89%e3%83%bc%e3%83%ab-%d1%86%d0%b5%d1%84%d0%b0%d0%bc%d0%b0%d0%bd%d0%b4%d0%be%d0%bb-%d8%b3%d9%8a%d9%81%d8%a7%d9%85%d8%a7%d9%86%d8%af/2019-04-17T09:21:01+00:00monthlyhttps://newdrugapprovals.org/2019/04/16/tegaserod-%e3%83%86%e3%82%ac%e3%82%bb%e3%83%ad%e3%83%89/2019-04-16T10:34:57+00:00monthlyhttps://newdrugapprovals.org/2019/04/15/22311/2019-04-15T09:37:57+00:00monthlyhttps://newdrugapprovals.org/2019/04/12/tak-981/2020-11-14T07:48:41+00:00monthlyhttps://newdrugapprovals.org/2019/04/10/biib-095/2019-04-11T09:40:29+00:00monthlyhttps://newdrugapprovals.org/2019/04/09/vnrx-7145/2019-04-09T10:03:42+00:00monthlyhttps://newdrugapprovals.org/2019/04/09/22300/2019-04-09T09:55:44+00:00monthlyhttps://newdrugapprovals.org/2019/04/08/lhc-165/2019-04-08T12:57:06+00:00monthlyhttps://newdrugapprovals.org/2019/04/08/ab-680/2019-04-08T12:55:21+00:00monthlyhttps://newdrugapprovals.org/2019/04/04/desloratadine-%e3%83%87%e3%82%b9%e3%83%ad%e3%83%a9%e3%82%bf%e3%82%b8%e3%83%b3/https://newdrugapprovals.org/wp-content/uploads/2019/04/01802-str1.jpg01802-str1https://newdrugapprovals.org/wp-content/uploads/2019/04/d7152-str1.jpgd7152-str12019-04-04T09:38:05+00:00monthlyhttps://newdrugapprovals.org/2019/04/03/cmx-8521-cmx-521/2019-04-03T10:17:24+00:00monthlyhttps://newdrugapprovals.org/2019/04/02/risdiplam-%e3%83%aa%e3%82%b9%e3%82%b8%e3%83%97%e3%83%a9%e3%83%a0/2019-04-02T10:23:56+00:00monthlyhttps://newdrugapprovals.org/2019/04/01/cladribine-%e3%82%af%e3%83%a9%e3%83%89%e3%83%aa%e3%83%93%e3%83%b3/2019-04-01T14:15:14+00:00monthlyhttps://newdrugapprovals.org/2019/04/01/e-2212/2019-04-01T14:10:44+00:00monthlyhttps://newdrugapprovals.org/2019/04/01/certolizumab-pegol-%e3%82%bb%e3%83%ab%e3%83%88%e3%83%aa%e3%82%ba%e3%83%9e%e3%83%96%e3%83%9a%e3%82%b4%e3%83%ab-%e9%81%ba%e4%bc%9d%e5%ad%90%e7%b5%84%e6%8f%9b%e3%81%88/2019-04-02T10:48:59+00:00monthlyhttps://newdrugapprovals.org/2019/03/30/fda-approves-treatment-cimzia-certolizumab-pegol-for-patients-with-a-type-of-inflammatory-arthritis/2019-03-30T03:14:10+00:00monthlyhttps://newdrugapprovals.org/2019/03/30/fda-approves-new-oral-treatment-for-multiple-sclerosis-mavenclad-cladribine/2019-03-30T03:07:58+00:00monthlyhttps://newdrugapprovals.org/2019/03/29/cevimeline-%e3%82%bb%e3%83%93%e3%83%a1%e3%83%aa%e3%83%b3/2019-03-29T13:20:19+00:00monthlyhttps://newdrugapprovals.org/2019/03/28/fda-approves-new-oral-testosterone-capsule-for-treatment-of-men-with-certain-forms-of-hypogonadism/2019-06-05T05:52:21+00:00monthlyhttps://newdrugapprovals.org/2019/03/28/batimastat-%e3%83%90%e3%83%81%e3%83%9e%e3%82%b9%e3%82%bf%e3%83%83%e3%83%88/2019-03-28T13:11:41+00:00monthlyhttps://newdrugapprovals.org/2019/03/27/abikoviromycin/2019-03-27T09:03:34+00:00monthlyhttps://newdrugapprovals.org/2018/06/15/rg-7604taselisib/2019-03-27T09:00:12+00:00monthlyhttps://newdrugapprovals.org/2019/03/26/industry-oriented-route-evaluation-and-process-optimization-for-the-preparation-of-brexpiprazole/2019-03-26T01:00:43+00:00monthlyhttps://newdrugapprovals.org/2019/03/21/%e3%83%96%e3%83%ac%e3%82%ad%e3%82%b5%e3%83%8e%e3%83%ad%e3%83%b3-brexanolone-allopregnanolone/2019-03-21T04:34:43+00:00monthlyhttps://newdrugapprovals.org/2019/03/19/prabotulinumtoxin-a-%e3%83%97%e3%83%a9%e3%83%9c%e3%83%84%e3%83%aa%e3%83%8a%e3%83%a0%e3%83%88%e3%82%ad%e3%82%b7%e3%83%b3a/2019-03-19T13:13:03+00:00monthlyhttps://newdrugapprovals.org/2019/03/18/triclabendazole-%e3%83%88%e3%83%aa%e3%82%af%e3%83%a9%e3%83%99%e3%83%b3%e3%83%80%e3%82%be%e3%83%bc%e3%83%ab/2019-03-18T10:30:50+00:00monthlyhttps://newdrugapprovals.org/about/https://newdrugapprovals.org/wp-content/uploads/2018/03/research.jpgresearch2019-03-16T13:20:44+00:00weekly0.6https://newdrugapprovals.org/2016/05/02/asp-3026/2019-03-12T13:27:07+00:00monthlyhttps://newdrugapprovals.org/2019/03/11/practical-and-scalable-synthetic-method-for-preparation-of-dolutegravir-sodium-improvement-of-a-synthetic-route-for-large-scale-synthesis/2019-03-11T10:14:35+00:00monthlyhttps://newdrugapprovals.org/2019/03/08/cenobamate/2019-03-11T10:13:27+00:00monthlyhttps://newdrugapprovals.org/2019/03/06/rovafovir-etalafenamide/2019-03-08T10:18:39+00:00monthlyhttps://newdrugapprovals.org/2014/12/08/bms-663068-fostemsavir-for-hiv/2019-03-07T10:30:38+00:00monthlyhttps://newdrugapprovals.org/2019/03/01/olacaftor-vx-440/2019-03-01T10:05:24+00:00monthlyhttps://newdrugapprovals.org/2019/02/28/development-of-an-efficient-manufacturing-process-for-a-key-intermediate-in-the-synthesis-of-edoxaban/2019-02-28T14:19:16+00:00monthlyhttps://newdrugapprovals.org/2019/02/17/macimorelin-acetate/2019-02-17T12:40:49+00:00monthlyhttps://newdrugapprovals.org/2019/02/08/caplacizumab-yhdp-%e3%82%ab%e3%83%97%e3%83%a9%e3%82%b7%e3%82%ba%e3%83%9e%e3%83%96/2019-02-08T11:25:10+00:00monthlyhttps://newdrugapprovals.org/2019/02/05/cannabidiol-%e3%82%ab%e3%83%b3%e3%83%8a%e3%83%93%e3%82%b8%e3%82%aa%e3%83%bc%e3%83%ab/2019-02-05T12:05:36+00:00monthlyhttps://newdrugapprovals.org/2019/02/04/voretigene-neparvovec-%e3%83%9c%e3%83%ac%e3%83%81%e3%82%b8%e3%83%bc%e3%83%b3%e3%83%8d%e3%83%91%e3%83%ab%e3%83%9c%e3%83%99%e3%83%83%e3%82%af/2019-02-04T09:44:35+00:00monthlyhttps://newdrugapprovals.org/2019/02/01/tiabendazole-%d1%82%d0%b8%d0%b0%d0%b1%d0%b5%d0%bd%d0%b4%d0%b0%d0%b7%d0%be%d0%bb-%d8%aa%d9%8a%d8%a7%d8%a8%d8%a7%d9%86%d8%af%d8%a7%d8%b2%d9%88%d9%84-%e5%99%bb%e8%8b%af%e8%be%be%e5%94%91-%e3%83%81/2019-02-01T10:23:32+00:00monthlyhttps://newdrugapprovals.org/2019/01/30/elapegademase-%e3%82%a8%e3%83%a9%e3%83%9a%e3%82%b0%e3%82%a2%e3%83%87%e3%83%9e%e3%83%bc%e3%82%bc-%e9%81%ba%e4%bc%9d%e5%ad%90%e7%b5%84%e6%8f%9b%e3%81%88/2019-01-30T15:05:56+00:00monthlyhttps://newdrugapprovals.org/2019/01/29/calaspargase-pegol-%e3%82%ab%e3%83%a9%e3%82%b9%e3%83%91%e3%83%ab%e3%82%ac%e3%83%bc%e3%82%bc%e3%83%9a%e3%82%b4%e3%83%ab/2019-01-29T11:30:08+00:00monthlyhttps://newdrugapprovals.org/2019/01/28/imetelstat/2019-01-28T10:44:38+00:00monthlyhttps://newdrugapprovals.orgdaily1.02026-04-03T02:48:49+00:00